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Abstract 
The topic of this thesis refers to the contribution of genetic variations, in 
which single nucleotide polymorphisms (SNP) can be included, to the 
manifestation and cause of disease. The facilitation of the treatment and cure of 
such conditions is done through identification and study of the cascade of 
biological mechanisms and processes; however the achievement of such goals 
is hampered by the formidable complexity and scale of the data sets involved in 
nucleic acid and protein analysis and thus the development of faster and 
cheaper methods is desirable. An intuitive trajectory for this development is the 
miniaturization of analytical methods with the incorporation of microfluidics 
which entails the manipulation of fluid analytes through channels and chambers 
on the microscale. This young field is projected to be instrumental in the 
realization of low temporal and financial cost analytical techniques. 
This thesis demonstrates the application of open-surface microfluidics to 
sequence DNA with the use of pyrosequencing. This method facilitates a 
reduction in instrument complexity and size and thus allows for functional 
integration or device disposability. Following incubation of the DNA with 
superparamagnetic particles, it was placed on a hydrophobic glass substrate. 
The DNA was then moved through microliter-volumes of mineral oil-coated 
water droplets via manipulation of the nanoparticles using a magnetic field; 
thus, these droplets could then be used either for pyrosequencing or for 
washing of the DNA strands. The reaction performance was determined, using 
the resequencing protocol with a 34 base pair (bps) of single-stranded DNA, to 
be highly linear for all 4 homopolymers events tested. De novo sequencing was 
performed with 51 and 81 bps while it was also verified that up to 7 
homopolymers could be determined. This method displays full compatibility with 
previously demonstrated open surface steps for sample preparation and so 
confirms PCR on a flat glass substrate as an integrated sample-to-answer 
protocol. 
All assays were based on primer extension via DNA polymerase. A 
microfluidic device consisting of microliter-volume droplet-to-droplet DNA 
transport via manipulation of magnetic particles was used in this work. The 
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difference in reaction kinetics for matched and mismatched configurations at the 
3’-ends of the primer-template complex was employed in sample differentiation. 
The assay combined pyrosequencing technology with a sequence-by-synthesis 
bioluminometric DNA sequencing probe on one common microfluidic platform. 
Base-by-base sequencing was performed to obtain accurate single nucleotide 
polymorphism (SNP) scoring data with microliter volumes. The application of 
magnetically actuated beads to facilitate virtual chamber reactions for chip 
based DNA analysis was presented. Single base incorporation was seen to be 
detectable with the use of this pyrosequencing assay. 
 
Keywords: DNA sequencing, single nucleotide polymorphisms, 
superparamagnetic particles, open surface microfluidics, magnetic actuation. 
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Zusammenfassung 
 
Mit Abschluss des Humangenomprojekts verlagert sich der Fokus darauf, 
zu verstehen, wie genetische Variationen, wie z. B. Einzelnukleotid-
Polymorphismus (SNP, single nucleotide polymorphism), zu Erkrankungen 
führen. Die enorme Menge an Sequenzinformationen müssen mit schnelleren, 
wirtschaftlicheren und leistungsfähigeren Technologien für die Analyse von 
RNA, DNA und Proteinen analysiert werden, um die die biologischen 
Mechanismen lebender Organismen zu verstehen und zu kontrollieren. Ein 
Ansatz ist die Miniaturisierung analytischer Methoden durch die Anwendung der 
Mikrofluidik, wobei Ströme in Kanälen auf der Mikrometer-Skala manipuliert 
werden. Es wird erwartet, dass Fortschritte in der Mikrofluidik-Chip-Technologie 
eine wichtige Rolle bei der Entwicklung wirtschaftlicher und schneller DNA-
Analysemethoden spielen werden. 
In dieser Doktorarbeit wird die Anwendung von Mikrofluidik an offenen 
Oberfläche für die Sequenzierung von DNA mittels Pyrosequenzierung 
demonstriert. Dies bietet Vorteile bezüglich der Instrumentengröße, der 
Einfachheit, Verfügbarkeit und Funktionsintegration, insbesondere in 
Kombination mit den vielfältigen und flexiblen Möglichkeiten der Mikrofluidik an 
offenen Oberflächen. Die DNA wurde auf superparamagnetischen Partikeln 
inkubiert und auf ein Glassubstrat mit hydrophobischer Schicht platziert. Die 
Partikel mit gebundener DNA wurden mithilfe von Magnetkraft über Tropfen in 
Mikroliter-Größe, beschichtet mit Mineralöl zur Verhinderung von Verdunstung, 
bewegt. Diese Tropfen dienten als Reaktionsstationen für die 
Pyrosequenzierung sowie als Waschstationen. Das Sequenzierungsprotokoll 
mit 34 Basenpaaren (bps) einzelsträngiger DNA wurde zur Bestimmung der 
Reaktionsleistung verwendet und zeigte eine ausgezeichnete Linearität für alle 
4 Homopolymere. Diese De-novo-Sequenzierung wurde mit 51 und 81 bps 
durchgeführt. Wir haben außerdem geprüft, dass bis zu 7 Homopolymere 
bestimmt werden können. Dieses Verfahren ist vollständig mit bisher 
verwendeten Schritten zur Probenvorbereitung an offenen Oberflächen 
kompatibel. Daher kann eine PCR als vollständig integriertes System von der 
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Probe bis zum Ergebnis auf einem flachen Glassubstrat zusammengestellt 
werden. 
In dieser Doktorarbeit werden Mikrofluidik-Anwendungen für 
verschiedene Genotypisierungsassay vorgestellt. Das übergeordnete Ziel ist die 
Kombination des Potentials des Chiplabor-Konzepts der Mikrofluidik mit 
Biochemie, um Verfahren für die DNA-Analyse zu entwickeln uns derzeit 
verfügbare Verfahren zu verbessern. Drei Genotypisierungsassays werden hier 
mithilfe von miniaturisierten Mikrofluidik-Methoden überprüft. 
Alle Assays basieren auf der Verlängerung von Primeren durch DNA-
Polymerase. Ein Mikrofluidik-Instrument mit Handhabung von Tropfen zu 
Tropfen für Magnetpartikel für Volumen im Mikroliterbereich wurde in diesen 
Studien verwendet. Das Mikrofluidik-Verfahren nutzt die Vorteile der 
unterschiedlichen Reaktionskinetik für komplementäre und nicht-
komplementäre Konfigurationen am 3‘-Ende des Primer-Template-Komplexes. 
Insgesamt beinhalteten die Assays die Anpassung der 
Pyrosequenzierungstechnologie, eines bioluminometrischen DNA-
Sequenzierungsassays basierend auf Sequenzierung durch Synthese, an 
dieselbe Mikrofluidik-Plattform. Basenweise Sequenzierung wurde in einem 
Mikrofluidik-Instrument durchgeführt, um genaue SNP-Scoring-Daten für 
Volumina im Mikroliterbereich zu erzielen. In dieser Doktorarbeit wird die 
Anwendung virtueller Reaktionskammern von Partikel, die magnetisch 
ausgelöst werden, für die Chip-basierte DNA-Analyse präsentiert. Die 
Inkorporation von einzelnen Basen mithilfe der Pyrosequenzierungsreaktion 
wurde auf diesen Partikel beobachtet. 
 
Stichworte: DNA-Sequenzierung, Einzelnukleotid-Polymorphismus, 
Superparamagnetischpartikel, offene Mikrofluidik, Mikrosystem, magnetische 
Betätigung 
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Chapter 1 
 
Introduction: DNA 
 
The human body consists of approximately 3,72x1013 cells[1], most 
containing the hereditary information of the genome in the form of 6x109 base 
pairs of deoxyribonucleic acid (DNA).[2] DNA molecules are the libraries in living 
cells where the information required for building a cell and an organism are 
stored.  
This subchapter 1.1 briefly describes relevant information over DNA and 
corresponding sequencing technologies and the microfluidics field, emphasing 
the inter-relation between both topics. 
 
1.1 Chemical structure of DNA and organization 
 
DNA is a linear polymer composed of single chemical units called 
nucleotides.[3-4] The number of nucleotides in a cellular DNA molecule can 
exceed a hundred million.[2] A nucleotide has three parts: a phosphate group, a 
deoxyribose and an organic base. The bases are adenine, guanine, cytosine 
and thymine; abbreviated A, G, C and T, respectively.[4] When the nucleotides 
polymerize to form DNA, the hydroxyl group attached to the 3’ carbon of the 
sugar group of one nucleotide forms an ester bond to the phosphate attached to 
the 5’ carbon of another nucleotide. This dictates the extremely important 
property of the orientation of the polynucleotide strand.[5] DNA consists of two 
associated polynucleotide strands forming a double helix. The sugar-phosphate 
backbones are on the outside of the double helix and the bases project into the 
interior. The orientation of the two strands is antiparallel and complementary to 
each other. The strands are held together by the cooperative energy of many 
hydrogen bonds in addition to hydrophobic interactions.[6-7] The opposite 
strands are held in precise register by a regular base pairing between the two 
strands: A is paired with T by two hydrogen bonds and G is paired with C by 
three hydrogen bonds.[7] 
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Figure 1: Chemical structure of DNA. DNA stores and transmits genetic 
information in all multicellular life forms. The sequences formed by the bps code 
for proteins which execute a wide range of physiological functions. a) The 
“backbone” made up of phosphate sugars which support the subunits of the 
polymer, each nucleotide consists of a phosphate group, a sugar group and a 
base. b) Adenine, thymine, guanine and cytosine are the bases present in DNA. 
c) These bases form base pairs (bps) with the second strand in the double 
helix; Adenine (A) always pairs with Thymine (T), whilst guanine (G) always 
pairs with cytosine (C). 
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1.2 Genomic variations 
 
This DNA is arranged into n chromosomes or in a plasmid depending on 
the organism (Figure 2) and the composition of the DNA bases within these 
macromolecules determines the genotype and contributes to the phenotype of 
an individual[8] (Figure 1). Consequently, alterations in chromosomes may lead 
to genetically related diseases (Figure 3). Cells are constantly exposed to 
agents and events that can be harmful to the DNA. Depurination, deamination, 
oxidation and methylation of bases are endogenous events that can change the 
base composition of DNA, while exogenous agents such as UV light, ionizing 
radiation and genotoxic substances may damage DNA by creating pyrimidine 
dimers, double strand breaks and adducts.[9-14] Several different gatekeeper and 
DNA repair systems exist to maintain DNA integrity, but occasionally these 
backup systems fail and mutations arise.  
 
1.2.1 Mutations 
 
Mutations can be divided into two classes; gross alterations and subtle 
alterations. Gross alterations involve changes in chromosome number, partial 
deletions of chromosomes, chromosomal translocations and gene duplications, 
while subtle alterations comprise of single base substitutions, insertions and 
deletions.[15-16] Mutations are common events in cancer and the ability to 
monitor them is therefore of great interest for diagnostic and prognostic 
purposes as well as in understanding gene function.[17] 
Therefore, detecting genomic variations is fundamental in genetic 
research. For example, in cancer research, mutation detection is vital for 
diagnosis but also gives insight into gene function[18]. Strains of microorganisms 
can also be identified by point variations in their genome, and, in recent years, 
the pharmaceutical companies have shown a rising interest in single nucleotide 
variations to be able to use “the right drug for the right patient”.[19] 
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Figure 2: DNA configuration. DNA is contained within the cells of every living 
thing though its organization varies within different life form. A binary distinction 
can be made between the two main DNA organizational conformations with 
organisms being either prokaryotes or eukaryotes. a) Prokaryotes. Bacteria are 
prokaryotic cells. They do not exhibit membrane-bound nucleus with their DNA, 
instead existing freely in the cytoplasm. Their monochromosomal DNA 
sequence, which is circular in aspect and located at the center of the cell, 
contains the genetic information required to support all cellular functions. 
Additional rings of bacterial DNA known as plasmids. Certain genes within 
these plasmids can code for antibiotic resistance which increases the probability 
of survival. Interbacterial exchange of plasmids is also possible through hair-like 
extensions from each cell’s surface known as pili. b) Eukaryotes: animal, plant 
and fungi cells are eukaryotes. All contain a membrane-bound nucleus in which 
the cell’s chromosomes are linear. Chromosomal DNA is tightly coiled around 
special proteins, known as histones, shown below. (adapted from 
http://www.bbc.co.uk/education/guides/z36mmp3/revision/2). 
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Figure 3: Figure 3: Mutations: During cell division, the DNA replication process 
is stringently controlled in order to preserve the genetic code held within the 
sequence of nucleotides. Despite this, encoding errors do evade this 
mechanism and exist in the copied genome as mutations, from which no protein 
or an altered protein can be expressed. Structure mutations affect the structure 
of one or more chromosomes (a) while single gene mutations affect only a small 
number of bases (b). Point mutations refer to the substitution of one codon 
alone which can result in missense, nonsense or a splice-site mutation (c). 
Frame shift mutations occur when insertions or deletions are not corrected 
(d).This implies that when nucleotides are grouped in threes to form codons the 
reading frame is shifted by one so that completely unrelated amino acids are 
outputted resulting in a most commonly junk protein (adapted from 
http://www.bbc.co.uk/education/guides/zc499j6/revision/2). 
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Gross alterations involve chromosomal number, chromosomal 
translocation, and partial deletion of chromosomes. These types of genomic 
alterations can be detected by rather simple techniques, such as microscopy 
and fragment analysis of implicated chromosomal regions.[20] Mutation detection 
of subtle sequence alterations, however, requires more sensitive techniques, 
is time-consuming and is more expensive. This perhaps explains why a wide 
range of techniques have been developed for this purpose. The growing 
number of methods indicates that a perfect technique which fulfills the required 
criteria and is able to detect all possible mutations/variations has yet not been 
described.[21]  
The techniques for detecting subtle sequence changes can be divided 
into three groups. The first is known as scanning methods and is used to search 
for unknown mutations in pre-defined sequences.[22] The second group is 
known as diagnostic methods and is used to search for analysis of mutations 
and variations at defined positions, such as hot-spot sequences and single 
nucleotide polymorphisms (SNPs)[23]. Since SNPs are much more frequent than 
hot-spot mutations and because most recent efforts have been focused on 
detecting single nucleotide variations, the diagnostic techniques will hereafter 
be referred to as methods for analysis of SNPs[24]. The third group of method is 
sequencing technologies that are used to reveal the exact nature of a mutation, 
regardless of being unknown or pre-defined[25]. 
Some of these techniques and their application fields will briefly be 
reviewed here. However, irrespective of the mutation status (known or 
unknown), all the techniques have advantages and disadvantages. Some are 
simple but do not detect all mutations while others are more complex and detect 
almost all mutations. Often, factors such as laboratory and personnel 
experience, required accuracy, required throughput, cost and project type have 
to be taken into account prior to selection of a method.[26-27] 
 
 
 
 
 7 
 
1.2.2 Single nucleotide polymorphisms (SNPs) 
 
The DNA content of one individual is 99.9 percent identical to any other 
person’s DNA. Differences in the sequence of DNA among individuals are 
called genetic variation. Genetic variation accounts for some of the differences 
between individuals, such as eye color, length, and blood group. However, 
genetic variation may also predispose some people to disease and explain why 
some respond better to certain drugs than to others. Therefore, detecting 
genetic differences between individuals and determining their impact on human 
health are fundamental in genomic research. The most common genetic 
variations are called single-nucleotide polymorphisms (SNPs). SNPs are single 
base-pair positions in genomic DNA at which different sequence alternatives, 
alleles, exist in normal individuals in a population (Figure 4). By definition, a 
position is referred to as a SNP when it exists in at least two variants for which 
the least abundant allele is present at or above a frequency of 1% in the tested 
population. Variations that occur at lower frequencies are not considered useful 
for genetic studies simply because they are not likely to occur in enough 
individuals. They are referred to as rare variants of the locus instead of SNPs. 
SNPs occur on 3 per 1000 base pairs in the human genome on average [28]. 
 
Figure 4. a) SNP position with two alternative DNA sequences (alleles); b) SNP 
incidence vs mutation incidence. The percentages shown (6% for SNPs and 
0,1% for mutation refer to occurrence in a given population). 
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There has been a large academic and industrial effort to discover and 
catalogue SNPs. To date, nearly 10 million SNPs have been catalogued and 
entered into public databases, such as the SNP Consortium (TSC) and the 
Human Genome Variation database (HGVbase). Recently, the haplotype 
mapping (HapMap) project was initiated in a joint effort by leading academic 
and commercial teams. A haplotype is defined as a series of closely linked 
alleles in a unit on the same chromosome. The haplotypes can contain a large 
number of SNPs, but a few SNPs are enough to uniquely identify the 
haplotypes in a block. The aim is to characterize the structure of sequence 
variation throughout the genome. SNP maps promise to increase significantly 
our ability to understand and treat complex diseases such as cancer, diabetes, 
asthma, vascular disease, and psychiatric disorders. Furthermore, their high 
prevalence of distributions across the genome [29-30] makes SNPs suitable for 
serving as genetic markers in linkage studies. Because DNA segments that lie 
near each other on a chromosome tend to be inherited together, SNPs can be 
used as an indirect way of tracking the inheritance pattern of a gene that has 
not yet been identified but whose approximate location is known. Therefore, 
pharmaceutical companies may also use SNPs as markers to discover new and 
better genes for identifying new drug targets for a number of common and 
complex diseases. 
As the number of identified SNPs increases, the demand will increase for 
efficient methods to score them to fully explore their impact on human health. 
Several methods that have been developed to meet the demand are reviewed 
in the subchapter 1.4 SNP genotyping technologies. 
 
1.3 DNA sequencing techniques 
Despite the wide range of techniques available for mutation detection, 
DNA sequencing is the most accurate method to determine the exact nature of 
a mutation or a variable position. DNA sequencing is considered to be the 
golden standard for mutation and SNPs detection, and for this reason, 
mutations and SNPs determined by scanning methods (described in subchapter 
1.4) must be confirmed by DNA sequencing. Among DNA sequencing methods, 
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conventional Sanger DNA sequencing has been used extensively, but 
techniques, such as sequencing by hybridization, mass spectrometry and 
pyrosequencing, have recently gained attention. 
In this subchapter, the focus will be aimed at [31] sequencing methods 
and technical parameters, such as sequencing speed, read length, and base-
call precision. 
 
1.3.1 Polymerase chain reaction (PCR) 
 
Despite not being a sequencing technique, many of such techniques are 
strongly based or dependent on polymerase chain reaction. 
The polymerase chain reaction (PCR) is an in vitro molecular biology 
technique used to amplify nucleic acids (DNA). It was originally developed by 
Kary Mullis (Nobel Prize, Chemistry 1993) during his time working at the Cetus 
Corporation in the 1980s. This technique is now standard in the majority of 
biology laboratories throughout the world and has been incrementally improved 
from its introduction in 1983 [32]. 
The reaction embodied in the PCR technique is a primer extension with 
serves to augment nucleic acid sequences in vitro. Its application in the field of 
molecular diagnostics has grown to the degree that its adoption as a tool for 
nucleic acid detection is nigh on universal and has made the technique a key 
tool in research, development and clinical diagnostics. 
Thermostable polymerase (most commonly derived from the thermophilic 
bacterium Thermus aquaticus and called Taq) has facilitated the isolation of 
freshly synthesized complimentary DNA with negligible reduction in enzymatic 
function. As the PCR amplication process is a power function, the increase can 
be as high as a billion fold in only a short number of runs which allows for the 
rapid determination of qualative and quantitative information about the 
sequence of interest. Since its advent, substantial improvements and 
modificaitons have been reported, including multiplex PCR[33], asymmetric 
PCR[34], hot-start PCR[35], nested PCR[36], RT-PCR[37], touchdown PCR[38], real-
time PCR[39-41], and miniaturization[42-43]. 
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The reaction entails the hybridization of the strands of a DNA molecule of 
interest to two synthetic oligonucleotides or primer sequences. The hybridized 
synthetic sections can then act as a substrate for a DNA polymerase to build a 
complimentary strand through sequential incorporation of the appropriate 
nucleotide. The whole process can be simplified to three steps (Figure 5) which 
are (i) the separation of dsDNA into its two complimentary strands at a 
temperature of =/>90ºC, (ii) annealing of the primer occurs at 50-75ºC and (iii) 
the extension optimally occurs between 72 and 78ºC [44]. The rate at which the 
changes in temperature occur, referred to as the ramp rate, and the duration at 
which the reaction remains static at each temperature and the number of times 
these cycle runs are repeated are controlled by the thermocycler. The 
progression of technological capacity throughout the intervening years have led 
to a considerable reduction in the ramp times via the use of electronically 
mediated heating blocks or forced convection heat exchangers for rapid 
temperature change. 
 
 
 
Figure 5: Schematic drawing of the PCR cycle (a) denaturation: DNA strands 
separate at temperature of 95ºC; (b) annealing takes places at circa 60ºC when 
the primer binds to the complementary bases at the end of the sequence of 
each strand; (c) elongation: at 72ºC a heat resistant DNA polymerase forms the 
complimentary sequence to the template strand thus forming a new double 
stranded DNA molecule. This process can be repeated for 25 – 30 cycles to 
amplify the sequence of interest 
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1.3.2. Dideoxy DNA sequencing by chain termination (Sanger DNA 
sequencing) 
 
The advent of the Sanger nucleic acid sequencing technique [45] has 
cause nothing short of a revolution within the biological sciences. A testament to 
the worth of this facile protocol, as already stated above, is the fact that it is still 
in use to this day, more than a quarter century after its inception, having 
amassed numerous improvements and advancements over this time. The 
modulus operandi of this procedure is the termination of enzymatically 
synthesized DNA. It is not possible for the dideoxynuleotide (ddNTP) to form a 
proceeding bond in a DNA sequence and thus, the synthetic process is disabled 
when a ddNTP is inserted into the forming chain. Four separate reactions are 
executed, one for each base after which each reaction can then be separated 
by molecular weight using electrophoresis. The sequence can be determined 
with the combination of the four electrophoretograms with gaps in one being 
filled with complimentary bands from the other three reactions. This principal is 
shown in Figure 6. 
Even with its labor intensive, low throughput tedium, Sanger sequencing 
remains in use to this day. One factor which can be attributed to its notable 
resilience within the modern laboratory is the technique’s ability to detect 
virtually any and all mutations as well as describe the specific nature of the 
alteration form the original. Additionally, it has an average read length of 500 
bases and is thus applicable to the genome sequencing and re-sequencing. 
The demand for long read-length, or the number of bases read per run, a 
key necessity for a DNA sequencing technique along with short analysis 
duration, low cost and high accuracy has obliged several modifications to the 
original technique. Automation in particular has been a key enhancer to the 
original method by increasing throughput and freeing up resources to facilitate 
the sequencing of extended lengths of DNA. 
Within the modern automated sequencing protocol, the electrophoretic 
separation of the strand lengths is combined with a fluorescent detection 
process via incorporation of a fluorescing moiety into the ddNTP markers and 
thus can be observed in real time through excitation of the strands by a laser 
beam (Figure 6). The sequencing techniques applied to this setup can 
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incorporate either one dye only or four-dye labeling system. The former 
employs one single dye moiety functionalized with one of the four bases 
creating, ddA, ddC, ddG and ddT; as each of these molecules have identical 
emission spectra, they must be separated in to four lanes for electrophoretic 
identification of their locations [46-47] (e.g. the Amersham Pharmacia Biotech’s 
A.L.F. DNA sequencer). The latter four-dye labeling system avails of the use of 
fluorescent moieties with dissimilar emission wavelengths thus enabling the 
simultaneous detection of the location of each base in one lane only [48] (e.g. 
Perkin Elmaer’s ABI DNA sequencer) which makes high-through put screening 
feasible. It is indeed the development of such a high throughput system that has 
facilitated the creation of software tools for the rapid quantification of 
polymorphisms and mutations within a sequence. However, the simultaneous 
detection of four partially overlapping emission peaks obliges the use of a 
computer algorithm to interpret and resolve the raw signal to its associated base 
with the accuracy of this sometimes hampering and delaying the identification of 
mutations and differences between sequences (Figure 7). 
 
  
Figure 6: Dideoxynucleotide: Dideoxynucleotides (ddNTPs) lack the 3’-hydroxyl 
group necessary for forming a phosphodiester bond. Consequently, ddNTPs 
prevent further elongation of a nucleotide chain and effectively terminate 
replication. The resulting length of a DNA sequence will reflect the specific 
nucleotide position at which the ddNTP was incorporated. For example, if a 
ddGTP terminates a sequence after 8 nucleotides, then the 8th nucleotide in the 
sequence is a cytosine 
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Figure 7: Sequencing: Dideoxynucleotides can be used to determine DNA 
sequence using the Sanger method. Four PCR mixes are set up, each 
containing stocks of normal nucleotides plus one dideoxynucleotide (ddA, ddT, 
ddC or ddG). As a typical PCR will generate over 1 billion DNA molecules, each 
PCR mix should generate all the possible terminating fragments for that 
particular base. When the fragments are separated using gel electrophoresis, 
the base sequence can be determined by ordering fragments according to 
length. If a distinct radioactive or fluorescently labelled primer is included in 
each mix, the fragments can be detected by automated sequencing machines. 
If the Sanger method is conducted on the coding strand (non-template strand), 
the resulting sequence elucidated will be identical to the template strand. 
 
 14 
 
There are three different approaches for dye labeling of the sequencing 
fragments. The first approach is the use of a 5’-end dye labeled sequencing 
primer [46, 48]. The second approach is to label the 3’-ends of the sequencing 
fragment by using dye-labeled dideoxy nucleotides (dye-terminators) [47]. 
Alternatively, fluorescently labeled nucleotides in an extension-labeling step can 
internally label the fragments [49]. 
Acrylamide slab gel electrophoresis has been the most widely adopted 
format for Sanger sequencing. Relying merely on slab gel technology was not 
sufficient to accomplish the challenges set by the Human Genome Project. The 
continual and unrelenting drawbacks of slab gel electrophoresis and the 
demand for more rapid sequencing and higher throughput led to the 
development of capillary electrophoresis (CE) [50]. The completion of the human 
genome was only possible due to several technological advances offered by 
CE. 
Electrophoresis is performed basically in an approach similar to slab gels 
with the advantage that each capillary contains a single DNA sample and 
therefore tracking problems are eliminated. 
 
1.3.3. Non-electrophoretic DNA sequencing methods 
 
A few DNA sequencing methods which are not electrophoretic based 
have been conceived in the last decades. These techniques have advantages 
and disadvantages compared to electrophoretic separation methods, depending 
on the type of applications performed and have promising applicability into 
miniaturized systems. 
 
Sequencing-by-hybridization 
 
 The sequencing-by-hybridization (SBH) technique is in fact based 
on the same principle as that of Southern blotting [51] and was simultaneously 
described by two independent research groups in 1988 [52]. It key premise was 
its ability to facilitate de novo sequencing with the development of hybridization 
arrays[53-54]. The technique entails the labeling and subsequent annealing of an 
unknown strand of DNA to an array of short length oligonucleotides (e.g. all 
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65,536 combinations of 8-mers) which is followed by the analysis of the 
sequence by the pattern formed from its hybridization with the array. For this a 
computer assisted assembly program is essential for the ultimate reconstruction 
of the correct order and sequence of the original strand (Figure 8). 
Because of the sheer scale of the data set from which the sequence is 
determined, the SBH technique has been prone to produce ambiguous results 
due to repetitive regions within the unknown sequence. Additionally, the 
formation of secondary structures within the target also reduces the accuracy of 
this technique. False positives are also caused by single base mismatches 
resulting from variations within the stability of the duplex of a complete match; 
this mostly occurs at the 3’-terminus. The effect of these issues can be 
minimized with the use of expression analysis or comparative sequencing 
between SBH microarrays though these issues have still not been solved in de 
novo sequencing. 
 
 
Figure 8 Sequencing-by-hybridization (SBH) (i.e. the reverse dot-blot format). 
An unknown target is labeled and hybridized with an array of known octamer 
oligonucleotides, with the formed hybridization pattern being interpreted to 
determine the sequence of the targeted DNA sequence. 
 
Sequencing-by-synthesis  
 
The approach referred to as sequencing-by-synthesis (SBS) was first 
described in 1985 by Robert Melamede [55]. This technique consists of the 
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sequential addition and incorporation of nucleotides in an extension reaction 
directed by a polymerase primer in such a manner that a strand complementary 
to the original forms through interactive addition of the four dNTPs. Figure 9 
shows the principle of SBH. 
The detection of incorporation of nucleotides in the primed DNA strand 
can be done either directly or indirectly. In the direct method, fluorescent labels 
are attached to the dNTPs to allow their detection with an appropriate detection 
method [56-57]. A draw back to this technique is the low number of bases that can 
be added due to the high failure rate of nucleotide incorporation which can in 
turn lead to desynchronization of the sequence being copied [57]. The post-
synthesis removal of the fluorophore acts as one further step in the process 
during which errors can be introduced. 
The indirect approach to detection employs natural nucleotides for the 
incorporation process. The pyrophosphate (PPi) released during the 
condensation polymerization reaction of the growing chain is then detected as 
an indirect indication of successful nucleotide incorporation [58-59]. The principal 
advantage of this approach is the ability to use unadulterated, naturally 
occurring nucleotides which in turn exhibits superior incorporation efficiency in 
the assay. The enzymatic process laid out in the scheme below details is based 
on the luminometric detection of ATP through the conversion of PPi molecules 
through an enzymatic cascade. 
 
(DNA) + dNTP
!"#$%&'()*,-.*
/000000000001 2DNA3 45 + $PPi$           (1) 
PPi$ + $APS
#67$.8'%98,('-.*
/0000000000001 ATP$ +$SO:
;<             (2) 
ATP$ + $luciferin$ +$O<
'8=>?*,-.*
/000001 AMP$ + $PPi$ + $oxyluciferin$ + CO< + $hv$       (3) 
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Figure 9. An illustration of the underlying principal of sequencing by synthesis 
consisting on the primed DNA template being subjected to iterative additions of 
nucleotides while in the vicinity of a DNA polymerase molecule, represented in 
the schematic as an oval shape. If a complimentary nucleotide is added, 
incorporation of it into the sequence can be conducted through a condensation 
reaction, releasing a PPi molecule and polymerizing the nucleotide to the chain. 
 
 
With the addition of dNTP to the reaction mixture, the DNA polymerase 
incorporates a complimentary nucleotide onto the 3’terminus of the strand which 
releases a PPi molecule into the solution. The free PPi molecule can then be 
observed via a coupled enzymatic reaction consisting of the ATP sulfurylase-
mediated conversion of PPi to ATP which is in turn consumed by the firefly 
luciferase enzyme to produce detectable fluorescence [58, 60]. Detection of the 
signal is done with a photon multiplier or a charge coupled device (CCD) 
camera. This method does not, however, lend itself to the robust sequencing of 
DNA and thus no further progression of the technique is reported in the 
literature. 
In progressive stages over the course of time, the sequencing-by-
synthesis method has been developed into a robust, easy-to-use sequencing 
method for DNA through improvements in the removal efficiency of nucleotides 
and additional modification of the sequencing-by-synthesis principal. The 
innovation of the Pyrosequencing technology developed and described by 
Nyrén and colleagues is a direct result of this [61-63]. 
 
 
 18 
 
1.3.4 Pyrosequencing technology 
 
The negation of unincorporated or excess dNTPs through total removal 
or degradation has been a key factor in the application of the sequencing-by-
synthesis technique to DNA sequencing. In the Pyrosequencing method, the 
removal of nucleotides is executed in one of two ways (i) the solid-phase 
approach uses a three-coupled enzyme-mediated reaction with interspersed 
washing steps and (ii) the liquid-phase approach which uses a combination of 
four enzymes in a cascade reaction which requires no additional washing step.  
 
Pyrosequencing by the solid-phase approach 
 
The solid-phase approach localizes the sequencing-be-synthesis method 
to the surface of a solid-phase. All four nucleotides are added and then 
removed in dispensing and washing steps with one additional nucleotide being 
added to the sequence each time. There are several solid-phases currently in 
use; magnetic beads are on more recent approach [64] where a DNA template 
and annealed primer is labeled with biotin and immobilized on a magnetic bead 
which is coated with streptavidin. The primed strand of DNA is incubated with 
the three enzymes, DNA polymerase, ATP sulfurase and luciferase. Following 
the addition of each nucleotide, the DNA template is immobilized through the 
application of a magnetic field to the magnetic particles, holding them stationary 
while the washing cycle is completed. 
 
There are several drawbacks to this method including the stripping of the 
DNA templates during the washing step, repetitive addition of enzymes and 
difficulties achieving a steady baseline; in addition, by its technical nature, this 
method does not lend itself to facile automation. A more promising approach is 
the use of a flow system to detect PPi and ATP on streptavidin coated 
substrates on which are biotin-mediated immobilization of ATP sulfurylase and 
luciferase. The use of a dynamic fluid flow should result in a more stable base 
line and in turn improve the detection of the sequence signal. This modified 
method is also more economical as the enzyme mixture does not need to be 
replenished after each addition of dNTP; additionally the constant fluid flow 
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serves to remove all inhibitory products in real time, thus rendering the reaction 
un-attenuated as well as making the system applicable to a microfluidic format. 
The solid phase Pyrosequencing method was successfully applied to the 
microfluidic paradigm by 454 Lifesciences (since acquired by Roche) [65]. 
  
Pyrosequencing by the liquid-phase approach 
 
The introduction of a nucleotide-degrading enzyme, called apyrase, was 
responsible for the breakthrough of liquid-phase Pyrosequencing [60-61, 63]. The 
introduction of this enzyme into the Pyrosequencing system negated the use of 
solid-phase separation and thus rendered obsolete the additional washing and 
enzyme addition steps synonymous with the latter. Apyrase exhibits high 
catalytic activity with low amounts of it efficiently degrading unincorporated 
nucleoside triphosphates in the reaction system first to nucleoside diphosphates 
and then to nucleoside monophosphate. Apyrase also serves to stabilize the 
base line with no fluctuations in the procedure as the enzyme catalysis reaction 
proceeds. 
This liquid-phase Pyrosequencing method utilizes a combination of four 
enzymes in a cascade reaction while the sequencing of the DNA strand is 
observed in real time. The reaction is begun with the annealing of a primer onto 
a single DNA strand serving as the template. Figure 10 presents a schematic 
description of the sequencing of a partially amplified DNA strand of the human 
papillomavirus (HPV) with Pyrosequencing devices. The four enzyme-catalyzed 
cascade reaction is shown whereby APS indicates adenosine 5’- 
phosphosulphate and hv is the light photons emitted by the bioluminescent 
enzymatic reaction. 
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Figure 10. The liquid-phase Pyrosequencing method is a non-electrophoretic 
real-time DNA sequencing method which relies employs the release of light 
from the luciferase-luciferin reaction as a detection signal to indicate the 
incorporation of a nucleotide onto the target strand of DNA. All four nucleotides 
are added in iteration to a mixture of four enzymes (1). The pyrophosphate 
(PPi) which is released in the DNA polymerase-catalyzed reaction is converted 
quantitatively to ATP by ATP sulfurylase (2); this provides the required energy 
to facilitate the oxidation of liciferin by firefly luciferase to generate a light (hu) 
(3). This light can be then detected by a photon detection device and observed 
in real time through the use of an appropriate piece of computer software (4a). 
Apryase then catalyzes the degradation of the unincorporated nucleotides at 
which point the cycle is complete and the system is ready for the addition of the 
next nucleotide (4b) 
 
 
In the liquid-phase Pyrosequencing method, the primer is hybridized with 
the template strand of DNA and the combined with the reaction enzymes, DNA 
polymerase, ATP sulfurylasem luciferase and apyrase, along with the 
substrates APS and luciferin. The four dNTPs are then sequentially added to 
the reaction. When the appropriate, complimentary, nucleotide is incorporated 
by DNA polymerase onto the 3’-end of the DNA template, PPi can then be 
released in an equimolar quantity to the incorporated nucleotide. 
The conversion of PPi to ATP is done quantitatively in the presence of 
APS by ATP sulfurylase. The ATP produced in this reaction the drives the 
luciferase-mediated production of oxyluciferin through conversion from luciferin 
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which in turn produces visible light proportionally to the original quantity of ATP. 
This light can then be detected by a photon multiplier tube or CCD camera and 
displayed as a peak in a pyrogram. Each signal of light is directly proporational 
to the number of nucleotides incorporated by the preceding reaction. Apyrase 
constantly degrades ATP and the remaining excess of dNTPs. Once the 
degradation process is completed, the systematic addition process is begun 
again. As this proceeds, a DNA strand complimentary to the template is formed 
with the sequence being interpreted through the displayed pyrogram peaks. 
The Pyrogram, produced by the Pyrosequencing process is analogous to 
the electropherogram in the Sanger sequencing method. A pyrogram can be 
read and observed in real-time as the reaction is ongoing and is the de facto 
display of all the sequence signal peaks, displaying all nucleotide additions, the 
dispensation order of nucleotides and the incorporated and unincorporated 
dNTPs which produce the base line. 
The modulus operandi of pyrosequencing relies upon the cooperation of 
several enzymes to allow the monitoring of the synthesis of DNA. Stability, 
fidelity, specificity, sensitivity, KM, and kcat are all critical parameters to the 
optimal performance of reaction. The enzyme kinetics can be studied in real-
time and are given in Figure 6. The ascending pyrogram curve displays a slope 
indicative of the activity of DNA polymerase and ATP sulfurylase while the 
height of the signal is indicative of luciferase activity. The slope at which the 
final curve decends indicates the of nucleotide degradation  
As described above, apyrase is the catalyst for the degradation of ATP 
with unincorporated or excess nucleotides being reduced to form nucleotide 
monophosphates and inorganic phosphate; this results in a steady and uniform 
decrease in the luminescence of the light signal to an intensity below that of the 
baseline of the pyrogram. When this point is reached, there is an additional 
internal lasted less than a minute to allow the degradation of the nucleotides to 
be completed so that the next dNTP can be added. The addition of the 
nucleotides can be repeated several times without any necessity to interrupt the 
process with a washing step. 
The enzymes employed in the Pyrosequencing technique are naturally 
expressed by various organisms. The chemistry standard to Pyrosequencing 
employs a modified 3’-5’exonuclease deficient Klenow fragment of E- coli DNA 
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polymerase [66]. The ATP sulfurylase which is used in the technique is a 
recombinant version originating from the yeast cell Saccharomyces cerevisiae 
[67] while the luciferase enzyme is taken from the American firefly Photinus 
pyralis. The apyrase is taken from Solanum tuberosum (Pimpernel variety) [68-
69]. The global time scale for the event from polymerization to light detection is 
between 3 and 4 seconds at room temperature. 
The conversion of PPi to ATP by ATP sulfurylase occurs in 
approximately 1.5 seconds while the generation of light from the production of 
luciferase is executed in less than 0.2 seconds [70]. The light generated exhibits 
a maximum wavelength of 560 nanometers which can be readily detected by a 
photodiode, photon multiplier tube, or a CCD-camera. 
There are many unique advantages to the Pyrosequencing technique 
amongst contemporary DNA sequencing technologies. One of these 
advantages is that mutations, deletions and insertions can be directly observed 
in the pyrgram (discussed in the next chapter) and that the order of 
dispensation of the nucleotides can be facilely programed. The ability to perform 
the sequencing process directly downstream of the primer, beginning with the 
first base after the annealed primer makes the design of the primer more 
flexible and thus makes this technique highly advantageous. The real-time 
production of the pyrogram as the pryosequencing process progresses, allows 
nucleotide incorporations and base callings to be immediately and continuously 
observed for each sample sequence. The Pyrosequencing method is finally and 
most importantly for scalable methods, easily automated for high throughput 
screening events. 
 
1.4 SNP genotyping technologies 
 
The first DNA sequencing method was described in 1977 by Sanger and 
co-workers [45]. This method, which came to be called Sanger DNA sequencing, 
is based on enzymatic chain termination, a set of single-stranded DNA 
molecules is generated, that is size-separated by gel electrophoresis. This 
method is by far the most common sequencing approach and has been further 
developed and optimized. Sanger DNA sequencing was the workhorse in the 
genome project and has been widely used in SNP discovery. However, its use 
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in SNP genotyping is limited by its low throughput and relatively high cost per 
sample. Pyrosequencing, an alternative to Sanger DNA sequencing, was 
developed in 1998 [61]. It is a real-time DNA sequencing method based on a 
four-enzyme mixture reaction that uses luciferase-luciferin light release to detect 
nucleotide incorporation by DNA polymerase into a target DNA This method will 
be described in detail in Chapter 5. 
Over the last ten years, significant efforts have been made to improve 
SNP analysis with alternative techniques, so a growing number of new 
technologies have been introduced. The alleles are distinguished on the basis 
of different reaction principles, and the methods are then combined with general 
detection methods to reveal the sequence information. With some few 
exceptions, the methods require a pre-amplification step by polymerase chain 
reaction (PCR) to produce enough DNA for testing. A number of high quality 
reviews have been published on the ever increasing number of SNP scoring 
technologies [23, 71-72]. Most of the methods can be divided between 
hybridization-based-methods [39, 73-76] (Figure 11), ligation-based methods [77-84], 
primer extension by DNA polymerase[29, 85-93] and invasive cleavage-based 
method [94-95].  
 
Figure 11. The principle of TaqMan 
assay. Two fluorescent dyes, a 
reporter (R) and a quencher (Q), are 
attached to the probes used to allele-
specific hybridize with the target 
DNA. When both dyes are attached 
to the probe, reporter dye emission is 
quenched due to FRET 
(fluorescence energy transfer) from 
the reporter dye to the quencher dye. 
During the PCR reaction cycle, the 
exonuclease activity of the 
polymerase fragments the probe, 
and the reporter molecule (R) is released. The PCR is followed in real time and 
an increase in fluorescence indicates the presence of the matching allele. 
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1.5. Detection 
 
A variety of techniques is used to generate signals and determine the 
allelic status of SNPs and are combined with general detection methods to 
obtain sequence information. The multiplicity of methods currently available is 
due in part to the combination of reaction principles with different detection 
systems. Figure 12 shows the different combinations used to analyze various 
reaction principles. 
Most of the common detection methods are based on the detection of 
light emission (fluorescence or chemiluminescence) with, in some cases, 
separation by gelelectrophoresis or on mass spectrometry. Fluorescence 
detection methods have greatly increased the sensitivity and ease of analyzing 
DNA. The availability of different fluorescent dyes and the diversity of their 
application have made them the most widely applied detection methods today. 
Fluorescence resonance energy transfer (FRET), in which energy is transferred 
from one molecule to another, is becoming useful in applications such as the 
DASH and TaqMan assay. Notable alternatives to fluorescence include 
chemiluminescence in the pyrosequencing system and mass spectrometric 
detection. 
 
Figure 12. SNP genotyping methods categorized by reaction principles and 
detection. 
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1.6 Next stage for DNA sequencing platforms 
 
DNA sequencing is considered the gold standard method for discovering 
new SNPs, but many alternative methods have been developed for known 
SNPs. Each method has unique ways of distinguishing a particular SNP 
position and is coupled with a detection method. There are at least 20 different 
SNP genotyping methods currently available [96]. A list of some of these SNP 
genotyping technologies is given in Table 1. The list does not cover all the 
methods but does give a representative picture of what is offered on the market. 
Many of these methods have been commercialized with a 384-well format and 
automated, such as the single-base extension based SNPstream, MALDI-TOF 
MS based Massarray System and Pyrosequencing’s high-throughput system 
[96]. 
Each SNP genotyping method has advantages and disadvantages and is 
suitable for a different range of applications [72]. Ultimately, choosing which 
method to use is based on the type of data to be generated, the number of 
samples to be processed, and the cost. That there is no single universal method 
for all situations promises further development of revolutionary methods. There 
is clearly a need for DNA analysis methods that are more specific, sensitive, 
fast, simple, automatable,  and cost effective than those presently available. 
 These demands are driving the rapid evolution of a diverse range of new 
technologies. Some of these technologies have been developed on miniaturized 
platforms, which in themselves offer numerous advantages. Some of these 
platforms will be described in the following Chapter 3. 
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Table 1. Selected SNP genotyping methods. 
Method Main advantage Company 
Hydridization   
DASH Inexpensive labelling Dynametrix, Ltd 
TaqMan No post-PCR treatment Applied Biosystems 
Oligonucleotide Ligation   
SNPlex Multiplexing capacity Applied Biosystems 
Primer extension   
SNPs stream Simple, versatile Orchid Bioscience 
SNaPshot Sensitive, no labeling Applied Biosystems 
MassArray Sensitive, no labeling Sequenom 
Pyrosequencing 
Informative, denovo 
sequencing 
Biotage 
Nuclease cleavage   
Invader assay Does not require PCR Third wave technologies 
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Chapter 2 
 
Introduction: Microfluidics and micro total 
systems (TAS) 
 
Microfluidics involve the manipulation, transport, and analysis of fluids in 
micrometer volumes. The field has bloomed and branched off into many 
different areas, for which a number of excellent general reviews are available 
(e.g. biological and chemical analysis [97-99], point-of-care testing [100], clinical 
and forensic analysis [101], molecular diagnostics [102] and medical diagnostics 
[103]). LOC systems are compact, often stand-alone systems featuring full 
process integration and automation to perform complex tasks. 
This subchapter 2.1 briefly describes relevant information over the 
microfluidics field, emphasizing the inter-relation between the chapters 1 and 2. 
 
2.1 Microfluidics 
 
Microfluidics involve the manipulation, transport, and analysis of fluids in 
micrometer sized volumes (Figure 13). Microfabrication technology is used to 
build microfluidic devices that exploit the inherent properties of liquids and 
gases in the microscale domain. These devices can accurately control minute 
volumes of fluid on a scale of nanoliters or picoliters. Making explicit use of the 
unique microfluidic effects, the microfluidic concept has today evolved towards 
the development of promising tools for analyzing biological samples in a way 
commonly referred as ”Lab-on-a-chip” (LOC). The concept of LOC or 
miniaturized total analysis systems (μTAS) as it is known today was proposed in 
early 1990s by Manz et al. [104]. Since that time the field has bloomed and 
branched off into many different areas, for which a number of excellent general 
reviews are available (e.g. biological and chemical analysis [97-99], point-of-care 
testing [100], clinical and forensic analysis [101], molecular diagnostics [102] and 
medical diagnostics [103]). LOC systems are compact, often stand-alone systems 
featuring full process integration and automation to perform complex tasks. 
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Figure 13 An example of laminar flow in a junction of 
microfluidic channels containing flows of blue, yellow and 
colorless dyes. The design of the shown chip consists of 
500 µm by 100 µm channels with the direction of flow being 
from left to right as indicated by the red and blue arrows. 
 
The main advantages of microfluidic systems over conventional systems 
include: minimized consumption of reagents, rapid response times (Table 2), 
well-controlled reaction conditions, parallel processing, speed of separation, 
excellent mass and heat transfer, low dead volumes, small power consumption, 
reduced manufacturing costs, portability, and disposability. The concept is still 
in its infancy, and significant technical challenges have to be overcome before 
the full potential of this technology is realized in biomedical research. Some of 
the challenges include fluid transport and the interfaces between the 
macroscopic and the microscopic environment, which include sample 
introduction and extraction as well as interrogation. 
 
Table 2: Comparison of time and costs for the complete screen using traditional 
methods and in microfluidic emulsions. 
 
Robot Microfluidic drops 
Total reactions 5 x 107 5 x 107 
Reaction volume 100 µL 6 pL 
Total volume 5,000 L 150 µL 
Reactions/day 73,000 1 x 103 
Total time ~2 years ~7 h 
Number of plates/devices 260,000 2 
Cost of plates/devices $520,000 $1.00 
Cost of tips $10 million $0.30 
Amortized cost of instruments $280,000 $1.70 
Substrate $4.75 million $0.25 
Total cost $15.81 million $2.50 
 
Adapted from Agresti J. J. et al, Ultrahigh-throughput screening in drop-based 
microfluidics for directed evolution, PNAS 2010, 107:4004-4009.  
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With these numerous advantages it is clear why microfluidic devices 
have received such interest in recent times, having great potential for 
revolutionizing chemical and biological processes. 
 
2.2 Microfabrication 
 
Microfluidic platforms can be fabricated involving different materials, with 
the function and ideal properties of the device playing the center role 
concerning the choice of substrate. Glass and silicon are usually processed 
using a photolithography and wet etching. [105-106] Glass offers advantages in 
terms of its optical transparency and stability with strong chemicals. Silicon is 
used less commonly than glass due to its lack of transparency but tend to be 
easier to mass produce. 
Hard polymers have gained attention as substrates, being examples 
poly(carbonate) (PC), [107] poly(methyl methacrylate) (PMMA), [108] and cyclic 
olefin copolymer (COC). [109-110] Their disadvantages is that they are usually not 
as stable to harsh chemicals and reaction conditions as glass, hence their use 
in chemical processes is more limited than with glass. [111-112] A big advantage 
though is that replication technologies can be applied to polymers enabling cuts 
in cost and time of production of disposable systems, important for example for 
point-of-care applications. Methods in use for fabrication for polymers 
comprehend injection moulding, [110, 113] imprinting, [108] hot embossing, [108, 114], 
and laser ablation. [115] 
Poly(dimethylsiloxane) (PDMS) [116] is definitely the most used material 
for chip fabrication in research environment because of its rapid and simple 
fabrication that enables fast prototyping, though it is not so useful for mass 
fabrication. PDMS devices can be prepared via soft lithography. [116-117] Shortly, 
a “master” is prepared with characteristics from the chip design as positive relief 
achieved with a photocurable epoxy. Next, the elastomer precursor and curing 
agent are mixed and placed over the master. The device is then left to cure, 
then peeled off the master and secured to a cover plate such as glass or 
PDMS. If the sealing is well performed, the channel network is then ready to be 
used. 
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2.3 Diffusion 
 
In the closed channels and chambers networks of microfluidic systems, 
the diffusion of molecules needed for certain reactions can be estimated using 
the Einstein-Smoluchowski equation (Equation 1). [118] 
 = !2"# 
Equation 1 
 
where x = distance (m), D = diffusion coefficient (m2.s-1), and t = time (s). This 
equation enables the enhancement or reduction of mixing in the microchannels 
while designing the chips, depending on the purpose of the system. 
Microfluidic systems have been proven to have many advantages over 
so called conventional systems and they have been particularly very 
successfully in areas such as separations and chemical or biological assays. In 
the case of biological assays, the big surface-to-volume ratio of a microchannel 
enables surface-based assays, in which for example, antibodies attached to the 
channel surface are used to capture antigens, which is overall carried out 
efficiently due to the reduced diffusion distances of antigens to the surface. In 
addition to these advantages, the surface-to-volume ratio can be even more 
increased by using functionalized microparticles, allowing further increases in 
reaction efficiency. [119] Subchapter 1.2.4 Microparticles explains how such 
particles are incorporated into these devices and the mechanisms by which they 
can be manipulated for performing a number of procedures, including bioassays 
and separations. 
 
2.4 Microparticles 
 
Polymers, glass, silica, gold, and inorganic crystals, are a few examples 
of materials particles can be fabricated from. depending on the, and their 
purpose and are available in a wide range of sizes (1 to 100000 nm). [120-121] 
Particles with diameters of 1 nm to 1 µm suspended in solution are known as 
colloidal suspensions, while particles between 1 µm and 100 µm are commonly 
referred to as microparticles, and when in suspension form coarse suspensions. 
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Polymer microparticles, are widely used for many processes because of they 
versatility, including bioanalysis and chemical procedures. Kawaguchi et al. 
wrote a review describing the fabrication methods of such particles and their 
possible applications. [120] Besides their wide range of possible sizes, they have 
a broad range of functionalization options from chemical (e.g. amine, carboxylic 
acid, epoxy) to biological (e.g. antibodies, antigens, single-stranded DNA) 
groups, which allows specificity for binding or reacting (Figure 14). Their small 
dimensions and volume causes them to have a large surface-to-volume ratio, 
providing a big surface area for reacting and binding on. In addition, the 
particles can respond rapidly to different parameters as temperature, pH, 
electric fields, and are highly mobile in solution since the viscous drag forces 
influencing them are low. Furthermore, some particles that possess soft layers 
enable water penetration which reduces the fluid resistance on their mobility. 
 
 
Figure 14. Microparticles functionalized with different surface groups (orange 
header) for different bio- and/or chemical procedures (blue footer). 
 
Given the many possible surface and physical properties of 
microparticles, they are widely used as solid supports for several bio and 
chemical procedures which include separations, immunoassays, and chemical 
reactions. [119-120, 122] Commonly, such procedures are carried out by suspending 
the particles into a solution or matrix containing target species or reagents that 
can then bind or react to their surface before removing the particles from the 
solution or matrix by sedimentation, decantation, centrifugation, or filtration. 
Despite of all the benefits of employing microparticles for assays and so on, the 
methods of separating them from the solution are quite time-consuming, 
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laborious, and inefficient, especially when the process involves several 
repetitions for washing purposes. In the last years, microparticle separation and 
assay techniques have been successfully integrated into microfluidic platforms, 
decreasing overall diffusion distances while maximizing binding efficiency and 
enabling more control over the fluid flow and particle mobility. In the next 
chapters, the theory of particle stability will be explained, and the literature 
related to the use of microparticles in microfluidic systems will be briefly 
mentioned, giving more attention to continuous flow procedures. 
 
2.4.1 Particle handling on-chip 
 
The strategies and advantages of using microparticles in microfluidics 
have been reviewed by Verpoorte [119] and Peterson. [123] Further applications 
for immunoassays have also been reviewed by Lim and Zhang. [124] In 
summary, there are two main methods for particle manipulation in 
microchannels: (i) trapping, and (ii) continuous flow. 
 
2.5 Miniaturized platforms for DNA analysis 
 
More traditional sequencing technologies have still disadvantages in 
terms of cost, speed, throughput, and sensitivity which results in lack of capacity 
to properly address the always increasing demand for more sequencing 
information. Therefore, there is a need to combine sequence information 
acquisition with faster, cheaper, and better technologies for DNA analysis. 
These technologies will most probably involve smaller reaction scales, evolving 
into nanotechnology direction. The processes are wished to be robust enough 
for general applicability while being simple enough for automation. Cost is a 
very important aspect for developing new and high-throughput technologies. 
There are two principal strategies behind designing new miniaturized assays 
while reducing costs: parallel assays in solid-phase microarray formats and 
homogeneous assays carried out in distinct channels of microfluidic devices 
[125]. There are many terms present in the literature describing miniaturized 
platforms, such as microarrays, microfluidic devices, bio- , DNA- and gene-
chips, and biosensors. A distinction must be made between microfluidic chips, 
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which typically involve fluids in channels, and chip-based microarrays, where 
DNA molecules are bound and arrayed on a solid support to investigate target 
DNA-probe interactions in parallel. In the following sections, an overview of 
miniaturized platforms based on different concepts for DNA analysis is 
presented. 
 
2.5.1 Microarray technologies 
 
A microarray is device designed for analysis consisting of an array of 
molecules as oligonucleotides, cDNA, PCR products, and others, which are 
immobilized at discrete, ordered or non-ordered, in the mM to mM scale solid 
substrate, enabling a great number of parallel analyses. In general, there are 
four steps involved in a microarray process: DNA immobilization on solid 
support, hybridization with a probe, detection, and data analysis. Several 
methods for the immobilization of DNA were developed by different research 
groups. In the beginning, two types of arrays were reported: synthesized in situ 
and pre-synthesized and spotted. Affymetrix Inc. (Santa Clara, CA, USA) and 
prepared synthesized oligonucleotide probes on a silicon support by using 
photolithography. [126] With suitable masking strategies, oligonucleotide arrays 
of known sequence and known location can be fabricated with very high 
densities (hundreds two thousands per cM2). The arrays can be created by two 
main methods: by pin-based fluid transfer [127], and piezo-based inkjet 
dispensers [128]. Several materials can be used as solid support for arrays, being 
glass slides the most commonly but other have been reported as well, as nylon 
membranes [129], beads [130], polyacrylamide gel pads [131], and activated 
dextran. [132]  
Once fabricated, these probe arrays are ready for hybridization. The 
nucleic acids to be analyzed, i.e., the target, are labeled with a fluorescent dye. 
The labeled target DNA is then incubated with the array. The formation of stable 
duplexes between the complementary probes and the sample DNA is facilitated 
by passive diffusion. The temperature and buffers determine the stringency of 
the hybridization condition. When the hybridization reaction is completed, the 
slide is inserted into a fluorescent scanner where patterns of hybridization are 
detected. The hybridization data are collected as light emitted from the 
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fluorescent-labeled target, which is hybridized to the probes on the array. 
Probes that perfectly match the target produce stronger signals than those with 
mismatches. Since the sequence and position of each probe on the array are 
known, the identity of the target nucleic acid applied to the array can be 
interpreted by a computer program. 
When the DNA microarray technology was introduced, it promised to be 
a massive parallel genotyping method using simple, allele-specific hybridization 
detection [133]. However, while DNA microarrays completely revolutionized the 
field of RNA expression analysis, microarray-based allele-specific genotyping 
has thus far found few applications. In gene analysis, the oligonucleotide (or 
cDNA) arrays target sequences with different compositions and hybridization-
based analysis can clearly distinguish between the different sequences 
involved. However, unlike gene-expression analysis, it is very difficult to design 
a high-density oligonucleotide array in which single-base mismatches can be 
resolved using standard hybridization conditions [134]. Thus, additional 
treatments and optimizations have been used to increase the specificity. 
One of the first strategies used to analyze SNPs in a microarray format 
was sequencing by hybridization (SBH) as described by Southern et al. in 1992 
[135]. A set of short oligonucleotides covering a large DNA fragment is arrayed 
onto a DNA chip. The precise sequence of the oligonucleotide at each location 
on the chip is known, and the pattern of hybridization of the fluorescently-
labeled DNA probes can be interpreted using an algorithm to give a sequence. 
However, while the method has high throughput capacity, it is not very accurate 
due to extremely small differences in the duplex stability between a perfect 
match and a mismatch at one base [136]. Alternative approaches involve 
hybridization followed by an enzymatic discrimination with DNA polymerases or 
DNA ligases, as described in Chapter 3 above. The combination of single-base 
extension with solid-phase bound oligonucleotides [137] has been successfully 
applied to microarray formats for parallel SNP analysis [137-139]. In this approach, 
each oligonucleotide printed on the array is designed complementary to the 
sequence immediately next to the 5’end of the target SNP. One version of the 
primer extension method involves placing the primer’s 3’end at the allelic 
variation instead of immediately 5’end of it and allowing the polymerase to fully 
extend the primer. DNA polymerase will only extend those primers that match 
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perfectly at their 3’ends. In this way, only one labelled nucleotide per reaction is 
required and higher detection signals can be obtained than with single-base 
extension since more fluorophores are incorporated during the primer 
elongation process [140]. However, this approach is not as specific as single-
base extension since it gives false positive signals that are twice as high as 
single-base extension [140]. The false positive signals are caused by the ability of 
DNA polymerase to extend certain mismatches if given sufficient time. In 
AMASE (apyrase-mediated allele-specific extension), the nucleotide degrading 
enzyme apyrase is used to remove the nucleotides continuously, which 
minimizes the risk of mis-incorporation during the extension reaction [141]. 
Ligation-assisted genotyping on microarrays is performed by ligating the single-
stranded target DNA to a probe hybridized to an immobilized oligonucleotide 
[142]. Ligation-based chemistry offers an advantage for multiplexing on 
microarray platforms because the interference is less between primers than is 
the case with base extension assays.  
Microarray technology is being proposed as the future platform for high 
throughput genotyping, and an increasing number of companies are active in 
this field, either with a whole new microarray platform or with conventional 
technology. Affymetrix remains the best known DNA chip-maker and continues 
to dominate the market. The Affymetrix GeneChipTM (Figure 15) is a highly 
dense array of oligonucleotide probes on a silicon support arrayed by 
photolithography. These chips have been used in a number of studies [143]. In 
the GeneChip system, each SNP position is composed of a series of 
oligonucleotides and complex computer algorithms are used to evaluate the 
numerous signals for each SNP. The need for large amounts of 
oligonucleotides for each SNP position is due to the difficulties in achieving 
hybridization stringency that is capable of differentiating a match and a 
mismatch configuration at one base. 
 
Figure 15. The Affymetrix GeneChip (http://www.affymetrix.com). 
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Nanogen Inc. (San Diego, CA) developed a completely different type of 
microarray chip that uses an electric fields in a microfabricated semiconductor 
device [144], as shown in Figure 16. Through the use of microelectronics, 
movement of charged molecules to and from designated test sites is achieved 
to obtain concentration at those sites. This allows rapid hybridization, and 
unhybridized molecules are removed by reversing the electrical potential. The 
active hybridization approach removes many of the limitations of the passive 
hybridization processes and can significantly improve the performance of DNA 
array analysis for a variety of diagnostic purposes. The incorporation of 
microelectronics limits the array density to 400 spots. However, the chip offers 
flexibility of design since reactions occur only at individually controlled charged 
test sites. Nanogen’s technology is an excellent demonstration of the 
applicability of electronics and may ultimately lead to complete automation to 
achieve integrated lab-on-a-chip systems. 
 
Figure 16. The NanoChip from Nanogen (http://www.nanogen.com). 
 
2.5.2 Microfluidics-based technologies 
 
The main driving force within microfluidic-based genomic research has 
been the need for a quick and easy way to perform DNA analysis. In the 
following Section, microfluidic chip-based systems for DNA analysis are 
described. 
 
Microchip-based CE for SNP analysis 
 
Electrophoresis is a separation technique used to fractionate and analyze 
both DNA and proteins. Traditionally, 1- to 5-mm thick gel slabs of usually 
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cross-linked acrylamide have been the most common format for electrophoretic 
separation. Over the past 10 to 15 years, significant efforts have been made to 
improve on this separation method and have resulted in the development of 
automated, high-throughput DNA sequencing and genotyping technologies. 
These efforts have led to the transformation of the platform system from thick 
slab gel to thin slab gel to capillaries and currently to a microfabricated chip 
format.  
In the early 1990s, miniaturized formats for analytical chemistry and 
biology in microfabricated chips were critically evaluated by Manz and co-
workers [104]. The first papers demonstrating the potential of microfluidic chip-
based analysis involved the fast separation of fluorescent dyes [145-146] and 
fluorescently-labeled amino acids [147] by capillary electrophoresis. Other groups 
then used microfabrication technology to further develop such systems. The 
advantages of microchip based capillary electrophoresis (CE) over conventional 
capillary are reported by a number of reviews in the literature [101-103, 146-149]. In 
general, almost all references report an enormous reduction in separation time 
when switching to microchip CE. The increase in speed is generally on the 
order of 10- to 100-fold relative to capillaries and slab-gel formats, respectively 
[101]. Increased dissipation of heat generated by joule heating and the ability to 
inject very small and well-defined sample plugs are some of the most important 
features of the microchip based systems. In addition, there is the possibility of 
integration with sample preparation. Figure 17 is a schematic drawing of a 
basic photolithography-defined microchip device for electrophoretic separations. 
The channel defined by Points 1 and 2 provides the separation, and the one 
defined by 3 and 4 is the sample-introduction channel. At the end of each 
channel, there is reservoir. These reservoirs also provide access for the 
electrodes. With the introduction of the cross-channel and double-T injector 
setup, well-defined sample quantities can be analyzed on electrophoresis 
microchips. Samples are typically loaded electrokinetically into the injector 
region by applying voltage between Points 3 and 4 and then separated by 
applying the electrical field between point 1 and 2. The detector is placed close 
to Reservoir 2 and is usually laser-induced fluorescence (LIF), but other 
methods such as mass spectroscopy [150] and electrochemical detection [151-152] 
have also been described. 
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Figure 17. Illustration of the 
main sections of a chip-
based electrophoresis 
system with either a (a) 
cross injection or (b) double-
T injection system. The 
vertical channel 3-4 is used 
for sample addition and the 
horizontal channel 1-2 as the 
separation/reaction portion. 
The detector is typically 
located on the far right, near 
Reservoir 2. Reproduced 
with permission of ACS 
Publications as seen in Anal Chem. 2002 Aug 15; 74(16): 4054–4059. [153] 
 
 
To increase the throughput even further, arrays of microfluidic devices 
have been developed [154-157] to provide parallel analyses. One way to achieve 
the necessary separation distance and high-speed analysis without sacrificing 
throughput is to fabricate a dense array of long separation channels on a single 
device. Systems of 16, 96, and 384 channels have been fabricated on 20-cm 
diameter glass wafers [156-158]. In these devices, geometrically optimized turns 
[159] were used to provide the necessary separation length. The radial chips in 
combination with the innovative high-speed rotary LIF scanner [160-161] and a 
high-pressure sieving matrix loader have increased the throughput capability of 
these devices. 
Chip-based CE for SNP analysis is becoming well-established. For 
example, fast analysis of the candidate gene for hereditary hemochromatosis 
[156-157], alleles of the D1S80 locus [162], and PCR products of Hepatitis C virus 
[163] have been demonstrated. A comprehensive summary table of articles 
describing chip-based genotyping using CE is given in the review by Verpoorte 
[101]. A number of companies are beginning to commercialize microfluidic DNA 
chips for electrophoretic separations. Caliper Life Science was one of the first 
companies established in the field of microfluidics and is presently developing 
lab-on-a-chip systems for various applications. Caliper’s LabChip system offers 
automated SNP interrogation using very small volumes in microchannel 
networks. A combination of pneumatic and electrokinetic forces are used to 
move fluids and perform separations on chip and to integrate sample 
 39 
 
pretreatment procedures. The first commercial instrument for microchip-based 
DNA analysis was the Agilent 2100 Bioanalyzer, by Agilent Technologies. Since 
then, a number of genotyping studies have appeared in the literature based on 
the use of this technology [101]. 
In conclusion, microchip-based CE has recently evolved as a promising 
method for genotyping. The more recent development of sequencing 
technologies in microfabricated channels may deliver significantly reduced 
reagent costs and increase throughput by decreasing reaction volumes and 
reducing run times. However, it is important to bear in mind that molecular 
diagnostic analysis is a multi-step process of which separation is only one part. 
The pre-electrophoresis steps including DNA extraction and PCR amplification 
have to be integrated with the separation. 
 
Polymerase chain reaction 
 
DNA amplification by PCR has become a key tool in modern molecular 
biology, but PCR is also the rate-limiting step in many genotyping applications. 
Therefore, this step needs to be speeded up. Conventionally, PCR is performed 
in benchtop instruments, whose large thermal mass limits the speed at which 
thermal cycling can be carried out, so the reaction times are on the order of a 
couple of hours or more. The benefits of miniaturization come from improved 
thermal-energy transfer, which reduces the typical cycling times from several 
minutes to 30 seconds or less. A number of groups have investigated 
microchip-based PCR systems in both disposable microchambers and 
microfluidic formats. Two different concepts have been reported for chip-based 
PCR. In the first configuration, the reaction mixture is stationary and entrapped 
in a thermocycling chamber that is typically micromachined in silicon or glass. 
The first papers dealing with this configuration were presented by Northrup and 
co-workers [164] in 1993 and Wilding and co-workers [165] in 1994. The devices 
consisted of a reaction chamber with the inlet and the outlet in silicon and 
sealed with Pyrex glass. The chamber was then placed on a conventional 
thermocycling instrument for heating and cooling. Later on, heaters and 
temperature sensors were integrated into the device [166]. The integration of 
optical windows in the silicon chamber permitted real-time monitoring of the 
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PCR reaction. The second configuration, which was introduced by Kopp et al. 
[43], involved a continuous-flow amplification system. The reaction mixture is 
pumped continuously through the chip and flows repeatedly through three 
different copper blocks side by side, providing three distinct constant 
temperature zones to ensure denaturation, annealing, and extension.  
 
Integrated systems for DNA analysis 
  
The vision of a lab-on-a-chip requires integration of all the steps onto one 
chip, in particular the integration of PCR and product analysis. Initially, only 
individual steps were performed in the microfluidic chips and only a handful of 
integrated genotyping devices have been developed until now. DNA sample 
preparation and integrated analysis were first published in 1996 [167-169]. In these 
systems, the PCR step was coupled with microchip CE to produce integrated 
DNA analysis systems. 
An integrated silicon chip that extracted DNA from a sample, separated 
fragments, and detected samples with an integrated photodiode [170] has been 
described. This impressive chip is capable of moving samples in microchannels 
with heaters, temperature sensors, and a fluorescence photodiode detector. 
Amplified DNA are mixed with intercalating dye, separated in a cross-linked 
polyacrylamide gel, and detected with the photodiode - all on board the 
microchip. Quake and co-workers have developed microfluidic systems using 
components fabricated with flexible polymer (polydimethylsiloxane) parts with a 
variety of microchannels and membrane valves for nanolitre-scale biological 
sample processing and analysis [171]. They have managed to integrate a variety 
of different biological processing techniques, such as amplification of nucleic 
acids and cell sorting in the same system, which allows parallelization [171-174]. 
 
2.5.3 Particle-based methods 
 
Nano- to micrometer-size particles are used routinely in molecular 
biology. The surface of these microspheres can supply active groups, such as 
carboxylic or amino groups, for covalent coupling of biomolecules. The high 
degree of flexibility in surface coatings allows them to be used in a wide variety 
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of applications. These applications include immunoassay, affinity assay, DNA 
hybridization assay, and protein-protein interactions. Microspheres have many 
advantages including a high surface-to-volume ratio, which enables reactions to 
be performed in lower volumes, increased diffusion - thereby decreased 
analysis time, and easy separation from the bulk of the reaction mixtures. 
Beads are mostly used in suspension mixtures and are interrogated individually 
by flow cytometry. In microfluidic devices that are not based on suspension 
mixtures and cytometric analysis, the beads must be controlled inside the chip. 
A number of different methods have been described to control the beads in 
confined areas. In this thesis, two different strategies have been used to capture 
beads: 1) a flow-through filter-chamber device consisting of grids of pillars and 
2) microcontact printing-based immobilization of beads without the use of a 
physical barrier.  
Bead-based systems have emerged as a promising tool for genomic 
applications. Some of the platforms for DNA analysis will be briefly reviewed 
below. 
 
Particle-based platforms for SNP analysis 
 
An alternative to DNA microarrays is an approach whereby the solid 
phase is composed of beads. Bead-based systems can be combined with most 
of the allele-discrimination chemistries used in the microarray format described 
earlier. One advantage of beads is that reactants can be added to them before 
or after they are immobilized. This opens up many ways to use reaction 
multiplexing, since mixtures of different beads and reagents can be integrated 
across various time and spatial coordinates. For example, samples from 
different individuals could be combined and simultaneously examined on one 
micro-surface. Doing this would require prior bead coding by chemical [175], 
spectrometric [176], electronic, or physical means [177] so that the results could be 
decoded and assigned to appropriate samples or assays. 
Luminex Corporation (Austin, TX, USA) has developed a genotyping 
platform based on microspheres that are internally dye-labeled with two 
spectrally distinct fluorochromes (red and orange) [176]. When the colors are 
combined in different ratios, codes of up to approximately 100-color resolution 
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with specific spectral addresses can be achieved. Hence, it is possible to 
perform a hundredplex detection reaction in a single tube. A third fluorochrome 
(green) is coupled to the DNA immobilized on the microspheres for the 
genotyping signal. The microspheres are interrogated individually by flow 
cytometry simply by rapidly flowing through two separate lasers, one laser to 
excite the two dyes contained within the microsphere and the other to excite the 
reporter dye on the immobilized DNA. This combination of encoded 
microspheres and flow cytometry is known as suspension array technology 
(SAT) and is a very fast detection method. The Luminex bead-based platform 
has been shown to work with several assay chemistries for SNP genotyping. 
Allele-specific hybridization [178] and the use of enzymatic allele discrimination 
by means of single-base extension [179-180] and oligonucleotide ligation assay 
[181] have been described. Recently, a microsphere based invasive cleavage 
assay has been described for genotyping SNPs directly from human genomic 
DNA samples without prior PCR amplification [182]. This assay uses a cleavage 
reaction that generates a fluorescent signal on the microsphere surfaces 
followed by flow cytometry analysis of the microspheres. 
In a different bead-based platform, commercialized by Illumina Inc. (San 
Diego, CA), microspheres are randomly assembled on the end of an optical-
fiber substrate [183-184]. The fiber-optic arrays are prepared by fusing together 
densely packed fibers into a bundle of about 50 000 individual fibers packed 
into a hexagonal matrix. Wells at the ends of each fiber are created by dipping 
the fiber-optic bundle into various chemical-etching reagents. Each well is 
dimensioned to accommodate a single microsphere and is typically about 3 to 7 
μm in diameter. A particular oligonucleotide probe is conjugated to each bead, 
which is followed by quantitative pooling of the bead types in a stock solution. 
This library of beads is then exposed to the fiber optic bundle and each bead is 
captured in a well of the fiber-array surface.  
Once the beads are attached to the wells, the concept is very similar to 
that of DNA microarray assays. However, oligonucleotides attached to the 
microspheres are spectrally registered in function of a random distribution in the 
wells rather than fixed surface positions predetermined during array fabrication. 
Since the beads are attached randomly, a decoding process is needed to 
identify the captured beads. This is accomplished by a series of hybridizations 
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with fluorescently-labeled oligonucleotides that are complementary to the 
capture probes on the beads. The combinations of different fluorescent dyes 
(with different excitation and emission wavelengths and intensities) allow each 
bead to be independently identified. The optical properties of the fiber are used 
to detect the fluorescent signal from the beads and the genotyping signal from 
the oligonucleotides of interest. The fiber-optic bundle is regenerated after the 
reaction by removing the beads. This highly miniaturized platform has 
enormous potential in multiplexing capabilities. 
Illumina introduced bead-chip arrays in a slide-shaped substrate. Each 
region can interrogate separate bead assays and can be configured in different 
sizes and densities depending on the application. Today, Illumina uses a library 
of 1500 bead types, each with a unique oligonucleotide capture probe ready to 
hybridize to a complementary sequence in a multiplexed SNP assay. The 
Illumina platform is compatible with most of the SNP assays described earlier. 
The platform produces accurate genotyping results with single-base extension 
[180, 185], ligation assay [181, 186], and allele-specific extension. Extremely high 
throughput is obtained by arranging the fiber-optic bundles to match the layout 
of the 96-, 384-, and 1536-well microplates. 
The DNA bead arrays described above have smaller feature sizes and 
higher packing densities than DNA microarrays. The advantages of this high-
density randomly distributed micrometer-sized bead-based DNA array include 
cost effective production of the bead arrays in seconds, high-throughput 
analysis, easy replacement with different or additional beads when different 
testing is desired, and facile regeneration of the sensor and substrate. 
454 Life Sciences developed an innovative approach to sequencing an 
entire genome that uses a microfluidic format with beads integrated in all the 
steps from the sample preparation, to amplification, and sequence analysis. 
They developed a novel platform, PicoTiterPlate, consisting of 44 μm in 
diameter microwells which are 50 μm deep for simultaneous amplification and 
analysis of over 300 000 beads in parallel [187]. Genomic DNA is fragmented and 
single-stranded DNA is captured at one copy per bead with complementary 
capture primers. Solid-phase PCR is performed to amplify the entire genome at 
one time in a water-in-oil emulsion. The beads are loaded into the 
PicoTiterPlate wells, each of which permits only one bead. Solid-phase PCR 
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can also be performed directly in the PicoTiterPlate [187]. Massively parallel 
sequencing is performed using bioluminometric sequencing-by-synthesis 
method. The reagents flow through the PicoTiterPlate wells and can diffuse 
uniformly into and out of the wells. The light generated by the nucleotide 
incorporation into the system is detected by a light detector. 
 
In this chapter, I described various miniaturized platforms for DNA 
analysis. The best-known example of a miniaturized tool today in this field is the 
DNA microarray, which has become increasingly important as a clinical 
diagnostic tool and is playing a central role in genomic research. Microarray-
based testing is faster and more convenient than serial testing and has largely 
revolutionized gene-expression analysis. In recent years, bead-based platforms 
have entered the arena. They are a more cost-effective than the traditional 
planar microarray, and beads can be integrated into the sample preparation 
steps. Microfluidic systems are more versatile than surface-based microarrays, 
and their importance in genomics is growing steadily. These systems promise to 
reduce cost and improve performance by integrating several processes that 
otherwise require a suite of bulky instruments and manual handling.  
These platforms all have both advantages and disadvantages, which 
makes it difficult to select a single platform as ideal for all applications. The 
meaningful exploration of genome variation for the purposes of 
bioscience/biotechnology will require meeting the ultimate goal of defining all 
genome variation in an individual at manageable cost and throughput. A 
combination of these techniques in conjunction with other innovative 
technological development will be necessary. 
 
 
 
 
 
 
 
 
 
 45 
 
Chapter 3  
 
Open surface microfluidics 
 
Over the last 10 years, a pursuit of an increase in throughput, reduction 
in material consumption and function integration to improve the analytical 
performance, led to downscaling molecular and cellular analysis by using the 
microfluidic format.[188-193] The early development of miniaturized assays greatly 
expanded from a limited simple fluidic operations to assays required complex 
and more sophisticated fluid handling. 
Microfluidics have been widely employed both in chemical and biological 
analysis for decades. Microfluidics are based in a variety of micro-
manufacturing techniques, allowing the use of little amount of reagents, giving 
access to accelerated reaction rates, process integration and multiplexicity. A 
clear disadvantage of such closed systems however includes the flow 
confinement which requires complex multilayer structure manufacturing. [194-199]  
Further, any gas in a closed microchannel liquid interface (e.g., enclosed air 
bubbles) in the operating fluid can lead to unexpected failure, which is another 
problem in miniaturization. Surface microfluidics is a new alternative to 
conventional microfluidics that solve the obstacles mentioned above, and will 
receive more and more attention in the microfluidic community.[200-202] 
Automatic microfluidic manipulation is one of the most relevant chores to 
be carried out by a lab-on-a-chip device aiming to compact and to integrate 
several chemical and biological functions into a microchip. Early microfluidic 
platforms, commonly utilizing single-phase fluids in microchannels, have made 
tremendous advances in the direction of fully operational instruments for 
miniaturized biochemical assays with increasing complexity. [203-207] 
Nevertheless, such continuous-fluid systems often require complex micropumps 
and microvalves as well as external appliances in order to carry on with liquid 
manipulation through the channel network interfering with the miniaturization 
development and future commercialization. Recently, droplet-microfluidics have 
gathered great interest. micro-droplet-based microfluidic system considerable 
attention.[208-209] In comparison to the continuous-flow platforms, the handling of 
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droplets offers more flexibility of operation, reduction of sample and reagents 
usage, as well as reduction of fabrication costs, particularly in the case of 
droplet-manipulation on an open surface. 
 
3.1 Droplets as reaction and transport units 
 
Many approaches have been adopted for droplet actuation on a surface, 
as electrowetting, [210-211], dielectrophoresis, [212] and magnetism. [213-215] Even 
though “digital-microfluidics” which mainly involves electrowetting has gathered 
popularity, the choice of magnetic actuation for droplet manipulation through 
particles present in suspension in the droplets to actuate offers relevant 
advantages. The range of magnetic particles ready for use, considering already 
the different particles possible to functionalize with many sorts of biomolecules, 
provides a strategy for both biomolecular separation and/or reaction. In addition, 
magnetic particles and droplets are simple to manipulate which cuts in terms of 
cost and size of the equipment involved. Magnetic particles have been already 
utilized for small-volumes transportation on miniaturized platforms. Garcia et al. 
[216-217] investigated the movement of viscous droplets caused by magnetic 
gradients on top of a superhydrophobic surface. Ohashi et al. [218] created a 
PCR instrument using droplets and magnetic transport.  Nguyen et al. [219-220] 
described their work on the effect of planar magnetic coils on ferrofluid-droplets 
and respective kinematics, as well as developed a circular closed-loop device 
using ferrofluid for fast PCR. [221-222] Magnetic particles  actuation on planar 
surfaces were also used in combination for bio-separations and -reactions. 
Shikida et al. [223-225] developed a system able to handle magnetic particles-
clusters by conducting these from well to well through an interconnect. 
Lehmann et al. [213, 226-227] showed an adaptable platform by fabricating an array 
of coils placed on a PCB plate to create a magnetic gradient, thus manipulating 
magnetic particles in an oil well with a hydrophobic base for extraction and 
fusion reactions. Pipper et al. [214] reported a micro-droplet platform for cell lysis, 
RNA extraction and purification, and real time RT-PCR, having all steps 
integrated in one device by actuating magnetic particles with an external 
magnet through an array of micro-droplets. In addition, these researchers 
broadened the platform for purification of certain cells with extraction of the 
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respective DNA. [215] In this platform, the particles are not only the support for 
biomolecular adsorption but also work as carriers, meaning that droplets are not 
only reaction vessels, but also transport units. The potential given by the 
flexibility of designing arrays of stationary- and moving- droplets according to 
demand and for different applications is enormous. 
Generally speaking, the flexibility involving droplet-volumes, obtainable 
particle mass in the droplets, speed of the particle motion, settings for droplet 
splitting or merging, among other variables, under magnetic actuation is 
enormous on an open surface. It is necessary though, that all these conditions 
are influenced by particle type, droplet size, surface tension, viscosity and effect 
of oil coating on droplet kinetics.  
 
3.2 Droplet actuation platform 
 
A conventional magnetic droplet-actuation platform is depicted in Figure 
18. Water-based droplets covered with a layer of mineral oil are placed on an 
hydrophobically coated glass substrate (glass slide). Hydrophilic magnetic 
particles are suspended in the droplets. An external magnet is placed beneath 
the slide holder and is used for droplet manipulation.  
 
 
Figure 18 Illustrative set-up and basic operations in a magnetically actuated 
droplet-system. 
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3.3 Droplet manipulation 
 
Figure 18 shows the fundamental response of droplets and droplet-
contained particles in magnet-actuated droplet handling. It starts with the 
attraction of the magnetic particles present in the droplet to the base of this 
same droplet by  the magnetic force (cause by the approximation of an external 
magnet). The particles can be moved by moving the magnet horizontally 
underneath the glass slide. The particles will form a cluster by being forced 
towards the wall of the droplet (contact line). The magnetic force will move the 
magnetic-cluster to the water/oil interface which results in droplet deformation. 
From this stage on, two different operations can be carried out. On one hand, 
droplet movement can be done if the droplet is fully “dragged” by the magnetic-
cluster. On the other hand, magnetic-cluster extraction can be done by splitting 
of a daughter droplet containing the magnetic cluster from the reaction mother 
droplet. [228] These two operations correspond to the fundamental ones in 
magnetically actuated droplet manipulation platforms. 
In preceding bio-separations and -reactions with droplets containing 
magnetic particles, the contained magnetic particles were used either as a 
droplet driver [216, 218] or as an extractable solid support.[213-214, 229] It is important 
to emphasize, that integration of operations in these cases wasn’t easy which 
makes crucial taking measures to reduce the conflict betweendroplet motion 
and particle extraction. In order to facilitate the bead extraction from the mother 
droplet, Shikida et al .[223-225] used a channel that worked simultaneously as a 
gate to stop the droplet from being dragged along by the magnet motion while 
the magnetic force pulled the magnetic-cluster daughter droplet from it. As 
another alternative, Lehmann et al.[213, 226-227] developed hydrophilic and 
hydrophobic patterns onto the glass substrate to restrain the droplets on the 
base surface. Superhydrophobic surfaces and smaller droplets size are also 
commonly used for droplet transport. By designing asnd preparing such 
surfaces with special topographies for droplet manipulation increases the 
complexity of  device fabrication. The work of Pipper et al., is an exception to 
this. This was achieved by combining solid phase extraction (droplet splitting) 
with clockwork PCR, using droplet transport to cycle the droplet though zones 
with the different PCR required temperatures. [215] (Figure 19) They observed 
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that, with a magnet moving at a steady speed, exclusively droplets with volumes 
below 10 µL could be stably transported without splitting into daughter droplets.  
 
 
Figure 19: Device integrating sample preparation and RT-PCR by using 
magnetically actuated droplet manipulation on an open surface (Pipper et al. 
2008). Reproduced with permission of Wiley-VCH as in [215]. 
 
Overall, one can say that in such system, the droplet kinetics and 
resulting operations are determined by the balnce between the horizontal parts 
of mainly three forces: the magnetic force (Fm) acting on the particle clusters, 
the capillary force (Fc) induced by the droplet deformation and the frictional 
force (Ff) between the oil-coated droplet and the substrate surface.  
 
Magnetic force, Fm 
 
 ! ="#$%& '"
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Equation 2 
 
where M is the mass of the magnetic particles cluster, r is the mass density of 
the magnetic particle material, c is the magnetic susceptibility of the particles, 
Bm is the magnetic field applied and µ0 is the permittivity of free space.
[230-231] 
From Equation 2 the maximum magnetic force that can be applied to the 
droplet along the magnet motion axis can be estimated: 
 !,!-. = /!,!-.' #$%& 
Equation 3 
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where Km,max is the maximum value of 
01
23 4(! that can be achieved for a specific 
magnet and device setup. 
 
Frictional force, Ff 
 5 6"/578)9:;< 
Equation 4 
where Kf is the friction constant, Rb is the radius of the base contact area 
between the oil-coated droplet and the substrate, m is the viscosity of the oil 
and U is the velocity of the drop.[220, 232] It is important to emphasize that the 
dynamic friction is proportional to the base radius of the oil-coated droplet, and 
not its contact area with the substrate, because the viscous drag in the 
proximity of the contact line dominates the sliding friction for small drops, whose 
radius is of the order of the capillary length, >?@ ="ABCDEFG H
I
J
 , or smaller.[232] Koil is 
the surface tension of the neighboring oil phase, r is the fluid density, and K is 
the acceleration caused by gravity. 
 
Capillary force, Fc 
When a magnet is moved horizontally away from a droplet, magnetic 
particles suspended in the droplet will be pressed against the side of the 
droplet, deforming it. This deformation generates a capillary force, which keeps 
the particles in the droplet. Over a sustainable capillary force, the particle 
cluster will detach and a smaller daughter droplet containing the particles will be 
extracted from the mother droplet. The capillary force at which this happens  
was given by [224] and can be defined by the following Equation 5. 
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Equation 5 
 
The analysis of the combination of the three forces described above can 
be illustrated with the three distinct regions in the operating diagram shown in 
Figure 20- The 3 described regions can be defined as follows: 
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- Region 1 – steady transport of the droplet takes place in this region, 
which means the magnetic force, Fm, is balanced by the frictional force, 
Ff, resulting in both the droplet and the magnet moving at the same 
speed.  
- Region 2. –magnet detachment happens in this region. Both the 
frictional force, Ff, and the maximum capillary force are greater than Fm, 
max. 
- Region 3. - Fm, max is greater than Fc, max in this region but Fc, max is 
smaller than the friction force which means that the magnetic pulling 
force acting on the particle cluster conquers the interfacial force and a 
particle daughter droplet splits off the mother droplet. 
 
Figure 20 Diagram illustrating the analysis of the combination of the main 
forces involved in droplet transport/merging. OB1, OB2 and OB3 represent the 
operating boundaries between three distinct operation regions. Reproduced 
with the permission from Royal Society of Chemistry as seen in [228]. 
 
3.4 Important parameters 
 
Magnetic properties 
 
Equation 2 demonstrates that the magnetic force required for a droplet 
operation, motion or split, is influenced by both the magnetic field’s strength and 
gradient together with the amount of used magnetic particles and their magnetic 
 52 
 
properties. Despite existing other ways of creating a magnetic gradient as for 
example arrayed coils [213, 219, 227], these do not remove the necessity of having a 
strong and homogeneous magnetic field which can be achieved with the use of 
a permanent magnet, and overall require a more complex fabrication procedure. 
Using this reasoning, a Nd-Fe-B permanent magnet placed on a translation 
stage that can be motorized vertically aligned and close to the substrate used 
for droplet manipulation can be used. Such setup generates strong magnetic 
fields and enables a considerably easy control of the magnet’s movement. 
Many types of magnetic particles are commercially available with 
different degrees of magnetic susceptibility and sources to answer the demand 
for several applications in bioseparation and bioreaction. These particles can be 
superparamagnetic, with a wider range of purposes in biosciences because of 
their resuspension properties, their greater surface area and slower 
sedimentation in solution, when compared to the ferromagnetic particles. The 
ferromagnetic particles possess in contrast very strong magnetic properties and 
are therefore quite simple to manipulate even in case viscous solutions are 
involved. 
 
Droplet size 
 
In summary, the frictional force rises with the increase of droplet volume 
and velocity, the maximum magnetic force and the maximum capillary force do 
not depend on the droplet volume but exclusively on quantity of magnetic 
particles loaded into the droplet. Due to this, the maximum velocities that can be 
achieved by a droplet will decrease as the droplet size increases. This tendency 
is illustrated in Figure 20, with the operating boundaries OB1 and OB2. 
This means, magnetically manipulated droplet systems are capable of 
droplet motion with volumes up to hundreds of microliters, while the so called 
digital-microfluidics typically involved droplet motion with volumes of few 
microliters by using electrowetting. [210-211]  
On Figure 20 also illustrates that a large droplet volume enables 
splitting, and therefore extraction, while achieving the same with smaller 
droplets is difficult. Such challenge can be conquered by readjusting the 
smoothness and roughness of the substrate used. These are aspects to 
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consider while designing devices using this strategy for bioassays, since the 
volume of the droplet dictates the quantity of reagents and material that can be 
analyzed and handled in one droplet.  
 
Surrounding oil layer 
 
So far, the presence of an oil medium has been needed to perform 
droplet manipulations. The oil aids the droplet manipulation by firstly, lowering 
the interfacial tension existing between the aqueous part of the droplet and the 
surrounding medium which makes splitting and extraction considerably easier.  
In addition, the oil also averts evaporation of the aqueous droplet and 
reduces the risk of contamination. Earlier studies reported that the magnetic-
bead-containing droplets were usually suspended or immersed in a container of 
oil,[213, 218, 226-227] which not only involves more complex fabrication process but 
causes as well handling and imaging issues. In alternative, as Pipper et al. [214-
215] suggested, the aqueous droplets can be sealed by a layer of silicone oil. 
 
Surface tension and viscosity of the aqueous phase.  
 
The interfacial tension of a droplet depends on the surface tension of 
both the aqueous and oil phases which can be altered by using different buffer 
solutions. This can influence the magnetic actuation in ways such as, for 
example, when the magnet in the proximity of the droplet is moved, not all the 
magnetic particles move onto the contact line of the droplet during transport 
which means that not all the magnetic particles loaded into the droplet 
contribute to the magnetic force. Consequently, the actual magnetic force acting 
on the droplet is reduced and the magnet disengagement might occur at a lower 
velocity than predicted. Therefore, droplets with higher viscosity should involve 
a lower manipulation speeds.  
 
Merging and mixing 
 
The covering oil layer should be thin, since droplet merging always takes 
place as soon as the two droplets are brought into contact. However, for 
 54 
 
droplets covered by a thick oil layer there is a higher challenge to merge both 
aqueous droplets, particularly when smaller volume droplets are involved. In 
such cases, a double-core emulsion comprehending both aqueous droplets is 
formed when the manipulated droplets merge. Because the two aqueous 
droplets are covered separated by a thick oil layer, the two droplets are actually 
separated and do not merge spontaneously. In some cases the passive droplet 
(recipient droplet) moves further away from the active droplet (manipulated 
droplet) which prevents merging from happening at all. 
 
3.5 OSM for DNA analysis 
 
Magnetic Manipulation of Droplets via Surface Energy Traps 
 
Zhang et al. [233] reported a surface energy traps (SETs)-based magnetic 
droplet manipulation platform for a wide range of fluidic operations. A SET is an 
etched area of high surface energy (hydrophilic) on a glass substrate coated 
with a low surface energy (hydrophobic) film to make droplet manipulation 
easier (Figure 21). Similar designs can also be used to functionalize 
superhydrophobically coated surfaces for bio-adhesion in electrowetting-based 
microfluidic systems.[234-236] The proposed design enabled a wide range of 
possible droplet manipulations, including droplet transport, fusion, particle 
extraction, and liquid dispensing.  
 
 
Figure 21. Droplet handling with SETs. A pattern with SETs is done on a 
Teflon-coated glass substrate using lithography. The SETs are patterned 
selectively with the aid of a SU8 mask by etching the Teflon film with 02 plasma. 
The Teflon film provides a low energy surface (superhidrophobic) for (I) droplet 
transport and (II) droplet fusion. These SETs can be used to (III) reference the 
contact line for extraction of magnetic particles from a droplet and (IV) to hold 
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volumes of solution to create new daughter droplets. Reproduced with 
permission of Wiley-VCH as in [233].  
 
SET-Assisted Magnetic Droplet Manipulation for serial dilution. 
 
Droplet microfluidics can be used for applications as biochemical assays 
without the need for complex fluidic networks of pumps and valvut not only. By 
using EWOD, an aliquot droplet can be easily created, but the resulting volume 
an be difficult to predict and to control, as it is influenced not only by the 
handling parameters as driving voltage and signal duration and also other 
aspects as surface roughness, surface coating and environmental humidity [237]. 
In comparison to EWOD, the biggest advantage of magnetic actuation is its 
capability to simultaneously manipulate both liquid and magnetic particles (MPs) 
at the same time for performing heterogeneous assay that need solid phase 
extraction [214-215, 238]. The magnetically manipulated droplets systems have 
been studied under various conditions and applied to different demands. [228, 233, 
238-239] To address the lack of applications on operations such fluid metering and 
dispensing this issue, further research was carried out with SET-assisted 
magnetic droplet manipulation technique [233] (Figure 22). SETs provide an 
additional mechanism for droplet control. Zhang et al. reported a magnetic 
droplet microfluidic platform for facile and rapid generation of serial dilutions 
using these SETs that meter and dispense fluid at defined volumes. They did 
this by demonstrating an antibiotic susceptibility test (AST) using the developed 
platform by preparing droplet-based serial dilutions of antibiotics using the SET 
method. [240] 
 
Figure 22. Scheme of SET-enabled magnetic droplet manipulation. (a) 
Illustration of droplet operations on the platform where SETs control the size of 
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the resulting daughter droplets. (b) Picture of an actual SET-based platform. (c) 
and (d) Side and top views of a SETs device. Reproduced with permission from 
Royal Society of Chemistry as in  [240]. 
 
Biocompatible open-surface droplet manipulation  
 
Since the earlier times of MEMS and microfluidic technologies there was 
interest in providing applications biomedical analysis. A few microfluidic devices 
for detection and sequencing of nucleic acids have been already developed. [241] 
The detection part can be carried out simply in a mere microchannel, which 
requires not as many pieces of large-scale equipment and simplifies the 
experimental procedure. [242] In one hand, such systems have been tested and 
reported with advancements in sensitivity, detection limit and specificity in DNA 
bio-sensing. [243] On the other hand, microchannel-based systems can be used 
exclusively to hybridization, since detection continues to require other peripheral 
instruments as for example a PCR device or a fluorescence reading for SNP 
identification. In addition, precision on controlling parameters as temperature 
(e.g. exact melting temperature of the DNA) which adds on the cost of a more 
complex integrated system. Such systems can be designed to identify SNPs, 
however they are unable to effectively detect variations with more than one 
consecutive nucleotide. Elghanian et al. reported a colorimetric method for 
detecting polynucleotides dependent on the optical properties of AuNP [244]  
however, the precise control of the experimental temperature and the sensitive 
manual handling was proven to require further improvement. The improvement 
of a new platform for multinucleotide polymorphism detection, requiring less 
manual handling, no thermal control and with straightforward detection results 
readout detection was the next objective to achieve. Therefore a new open-
surface droplet manipulation microfluidic platform was designed, integrating a 
module for pneumatic droplet control and a superhydrophobic surface to detect 
multinucleotide polymorphisms. This was reported by Huang et al. in 2014 while 
adopting a novel colorimetric approach based on the growth of AuNP probes 
mediated by DNA hybridization in order to detect DNA present in a sample. [245] 
The driving energy in this case was pneumatic suction and the multinucleotide 
polymorphism could be detected directly with the naked eye. The proposed 
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platform was used for and found suitable for biological and chemical 
applications. (Figure 23) 
 
Figure 23 Illustrated principle of the platform proposed by Huang et al. 2014 
[246]. (a) Loading of the droplet containing target DNA and the probe-modified 
AuNP; (b) mixing and hybridization step; (c) further mixing and growth steps (d) 
shift in the absorption peak which can be detected with the naked eye. 
Reproduced with permission of Royal Society of Chemistry. 
 
Digital microfluidics for sequencing 
 
 The successful use of electrowetting-based digital microfluidics in DNA 
sequencing was demonstrated by Boles et al. 2011 [247] with pyrosequencing 
chemistry. (Figure 24). The earlier success of using digital microfluidic 
pyrosequencing to picoliter scale was demonstrated by Welch et al. [248] The 
premise was that scaling down the amounts and volumes in the processes 
would enable not only higher density of reactions, but also faster operation 
rates, and simpler fabrication involving lower costs per device. 
Most next-generation sequencing technologies available reach high 
levels of throughput with the parallelization of large number of solid-phase 
reactions within one transport or solution compartments. This results in a 
plateau of the cost and time generated by these systems after a few hundred bp 
of sequence. Barcoding strategies do in fact reduce the sequencing costs per 
sample, however, the initial cost considering the required sample preparation 
and library construction is substantial. The use of droplets as single and distinct 
transport units for small amounts of reagents in a precised control manner gives 
great flexibility to modulate the throughput, cost, or run time according to the 
requirements of a specific application. Some clinical applications require just a 
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small sequence, however ideally at a low cost per run and with a rapid 
turnaround time. Borman et al. [249] showed that sequencing 35 base pairs 
located within the ITS2 region was enough for the correct identification of more 
than 40 different pathogenic yeasts. Implementing pyrosequencing as described 
above has advantages considering instrument size, complexity, cost, 
disposable cost, and obtainable degrees of functional integration. The fluid 
control was obtained with electrical switches and the instrument was built quite 
compact and inexpensive for portability potential. The disposable cartridge 
consisted of a PCB top. With this device, the flexible potential of digital 
microfluidics opened possibilities of combining DNA sequencing with upstream 
processes such as PCR, sample preparation, or cell-based manipulations within 
an integrated device. 
 
 
Figure 24. (A) Photograph of the multiwell-plate-sized PCB cartridge, (B) 
photograph of the full device and (C) illustration of the cartridge with the 
mapping and highlighting of different regions and spots. [247] Reproduced with 
the permission from American Chemistry Society. 
 
 Miniaturization research and development, together with system 
integration, is strongly directed by the quest of further costs reduction 
while reducing consumables, increasing throughput and promoting 
further automation. 
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Chapter 4 
 
Motivation 
 
4.1 DNA, genome and microfluidics 
 
Deoxyribonucleic acid or DNA is a double-stranded molecule inside the 
nucleus of a cell and carries the genetic instructions for making living 
organisms. The information is carried in the form of a genetic code and is 
determined by the sequence of the four bases: adenine (A), thymine (T), 
guanine (G), and cytosine (C). The structure of DNA was first described by 
James Watson and Francis Crick in 1953 [250] for which they were awarded the 
Nobel Prize. In April 2003, 50 years later, one of the most important scientific 
achievements in history was announced - the sequence of the human’s 3.2-
gigabase genome [251]. This accomplishment was the work of thousands of 
scientists from around the world in the public Human Genome Project [251] and 
the private Celera genome project [252]. Although it took about 20 years from 
conception to completion, the sequence of the genome itself was produced over 
a relatively short period with coverage rising from about 10% to more than 90% 
over roughly fifteen months [251]. Crucial factors in achieving the exponential 
efficiency of sequence throughput were the automation in the form of 
commercial sequencing machines, the process miniaturization, and the 
optimization of biochemistry and algorithms for sequence assembly [25] (Figure 
25). 
With the completion of the draft of the human genome, the challenge now 
is to understand how the genes interact with proteins, drugs, metabolites, and 
other molecules in the cell to control its functions. Identifying genetic variations 
between individuals will increase our understanding of genetically related 
diseases and disorders and lead to molecular-level treatment specific to each 
individual. Consequently, a great deal of effort is being put into the development 
of robust, cost-effective, and high-throughput technologies for genetic-variation 
analysis. At the same time, in the past decade, there has been a growing trend 
towards downscaling molecular and cellular assays into a microfluidic format to 
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improve assay performance for enhanced throughput, reduced material 
consumption, and functional integration (Figure 26 and Figure 27). Thus, the 
work described in this thesis focused on developing methods for genetic 
variation analysis primarily by system miniaturization based on microfluidic 
technologies towards low-cost and accessibility. To put this work in context, the 
most common types of genetic variation are described briefly, and the current 
technologies involved in genetic-variation analysis are reviewed. An overview of 
current miniaturized formats for high throughput analysis is presented. Finally, 
my work in this thesis  
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Figure 25: A Timeline of 
a few advances resulting 
in genome-scale 
engineering. Everything 
started in 1953 with 
Watson and Crick and 
the discovery of the DNA 
double helix structure. In 
1977, Frederick Sanger 
developed one of the 
first DNA sequencing 
methods and since then 
the technology has 
advanced rapidly, 
becoming extremely popular and developing. Afterwards, in 1990 a 13 year-long internationally funded effort was created to decode 
the entire human genome. Next generation sequencing technology started to be developed, and the technology advanced and still 
advances at a rapid pace. The most recent methods are take nanotechnology to create further faster and more effective readings 
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Figure 26: A flow diagram marking key developments in the microfluidic field from fabrication approaches and functional developments to 
a few applications. [1] In the 1960s, technologies using microfluidics were improving both bioanalytical speed and resolution for a few 
analytical tools. [2-4] Starting in the 90s, major improvement in fabrication enabled researchers to quite using pulled glass capillaries and 
start using micro-fabricated glass or polymer microchannels. [5-7] Functionalization of portions of increasingly complex microfluidic 
devices is achieved [8-9]. The increasing availability of fluidic components and number of experts in different areas of the microfluidics 
field have opened possibilities of new biological applications including new single cell measurements[10-12], high-throughput monoclonal 
antibody screening[13], analysis of dynamic phenomena[12, 14-15] and organ-on-a-chip platforms[16]. 
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Figure 27: Microfluidics for point of need testing – roadmap. (Source: Saphire 
Applications and Market 2016: LED and Consumer Electronics report, 
September 2016, Yole Développement) 
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4.2 Objectives 
 
 Summarizing the overall motivation given in the previous chapter, the 
objectives of this thesis are: 
 
1. To study the potential of droplets as virtual reaction chambers for nucleic 
acids handling. 
 
2. To investigate virtual reaction chambers as a platform for DNA 
sequencing. 
 
3. To devise and test the platform for single nucleotide polymorphism 
analysis. 
 
4. Provide scope and perspective for the research trajectory towards more 
efficient and stable low cost and simple sequencing platforms. 
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Chapter 5 
 
OSM and Virtual Reaction Chambers 
 
The general aim of the research presented in this thesis is to develop a 
miniaturized platform for sequencing nucleic acids and detecting single-base 
variations. The study involves the design, microfabrication and application of a 
microfluidic platform: a microfluidic approach based on surface droplets (refer to 
subchapter 1.3.1) and magnetic actuation (refer to subchapter 1.3.2) is 
evaluated to handle nucleic acids, more particularly DNA. The feasibility of 
adapting pyrosequencing to a microfluidic platform was also investigated and a 
novel approach involving on-chip bead-based DNA analysis was developed for 
DNA sequencing and SNP detection. 
The choice of platform for the research described in this thesis, besides all 
the arguments given already, is also connected with the research line of my 
supervisor and colleagues. During the course of my stay in KIST-europe, 
University of Saarland, under the guidance of Andreas Manz and supervision of 
Pavel Neuzil, our group pushed the boundaries on the use of surface droplets 
as reaction units (Virtual Reaction Chambers, VRC). 
The stability of these VRCs was tested and reported in several ways by 
colleagues, mentioned and cited below to contextualize the research carried out 
for this dissertation. 
 
5.1 Microfluidic superheating for peptide analysis 
 
Microfluidic devices provide optimal conditions for superheating and sample 
handling without requiring manual labor, being three factors associated with 
these conditions the absence of: (i) nucleation sites, (ii) temperature gradients, 
and (iii) mechanical disturbances. An application for this microfluidic 
superheating was the energy-based fragmentation of polypeptides which 
drastically shorten analysis times and simplify sequence identification and 
conformation. This was achieved reported by Altmeyer et al. using the VRCs as 
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the suitable vessel to perform successfully thermal peptide cleavage through 
superheating. [253] 
 
Figure 28. Two superheating devices: (A) photograph of two VRCs on a glass 
slide on top a silicon heater. (B) Drawing of the VRC. (C) Fused-silica capillary 
placed in a brass heater. (D) Drawing of the capillary system. [253] Reproduced 
with the permission of American Society of Chemistry. 
 
5.2 Superheating for protein thermal stability analyses 
 
A similar approach was applied for a few different proteins, as GFP, BSA 
and Taq polymerase for protein stability analysis and reported by Ahrberg et al. 
It was demonstrated that thermostable proteins can be easily analyzed using 
the capability of VRCs to superheat water to temperatures over 100 degrees 
Celsius. While in other methods as scanning calorimetry extensive pressurized 
set-ups are require to measure above 100 degrees, the experimental set-up 
required for this work is simpler and measurements could be performed within 3 
to 5 min. Furthermore, sample consumption is still lower using VRCs with 
sample volumes between 100 to 300 nL than for other fluorescence methods 
performed with commercial machines. [254] 
 
Figure 29. Photograph of the heating chip with two VRCs on top. It is possible 
to perform the parallel heating of up to four samples. [254]. Reproduced with 
permission from Royal Society of Chemistry. 
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5.3 qPCR with VRCs for different applications. 
  
Many publications, being the first ones from 2006 with a first 
collaboration between Pavel Neuzil and Juergen Pipper, were achieved by 
developing platforms for the use of VRCs for PCR and sample preparation [214-
215, 255-258]. 
 The latest progress comprehends application of qPCR in the smallest 
instrument up to date[259], improvement of the throughput[260] and for Ebola 
detection[261] (Figure 30). 
 
Figure 30. (1) Photo of the handheld real-time PCR device [262] (2) 
Representation of the data resulting from the Real-Time PCR [260] (3) Photo of 
the device for Ebola detection. [261] Reproduced with permission from both 
Springer Nature and Royal Society of Chemistry. 
 
 
5.4 My published research 
  
- Fast spore breaking by superheating[263] 
- Pyrosequencing on a glass surface[264] 
 
5.5 Wrap up 
 
Quoting Neuzil: 
“Stationary systems are simple, therefore more trustworthy than dynamic 
ones. In addition, complex systems have a much higher chance of failure than 
simple ones.” 
Therefore, “simplicity” is the keyword behind the goals of this thesis.  
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Chapter 6 
 
Materials and Methods 
 
The overall objective of the research presented in this thesis is to 
develop an accessible miniaturized technology for sequencing nucleic acids and 
detecting single-base variations. The study involves the design and 
microfabrication of a microfluidic platform with attention being given to the 
biological compatibility of the process and the evaluation of the biological 
assays. A microfluidic approach based on surface droplets (refer to subchapter 
1.3.1) and magnetic actuation (refer to subchapter 1.3.2) is evaluated to handle 
nucleic acids. The feasibility of adapting pyrosequencing to a microfluidic 
platform was also investigated and a novel approach involving on-chip bead-
based DNA analysis is was developed for DNA sequencing and SNP detection.  
In this chapter more details on the materials and experimental design 
approached are described. 
 
6.1 Glass substrate 
 
Recently, maneuvering droplets on an open surface offers an alternate way 
of performing bioassays at the micro level [210, 265-267]. Here, sample droplets are 
confined by surface tension and function as reaction or transport units (virtual 
chambers). In order to actuate these droplets, magnetic force[214-215, 228, 233, 238-
239, 268] has been employed to enable a wide range of droplet operations 
including dispensing, moving, splitting and mixing[233, 269-270]. 
These virtual reaction chambers are prepared on a flat substrate. For this 
flat substrate it was decided that the material should be easily accessed (for 
potential in point-of-care applications it must be disposable and easily replaced) 
and not rise issues with surface modifications. Due to this, and considering 
previous platforms using a VRC system [213-215, 228, 253, 256, 271], a microscope 
glass cover slip was selected as the flat substrate. 
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The microscope glass cover slip was coated with fluorosilane 
(heptadecafluoro-1,1,2,2-tetrahydrodecyl)trimethoxysilane, (tridecafluoro -
1,1,2,2-tetrahydrooctyl)trichlorosilane (FOTS) or 1H, 1H, 2H, 2H-perfluorodecyl-
triethoxysilane (FAS-17), typically by a chemical vapor deposition (CVD) 
process at temperature of ≈150°C. This was chosen over 
Polytetrafluoroethylene, PTFE (being best known as the commercial brand 
Teflon) coating due to materials cost and high similarity of contact angle results 
between both coatings. 
 
6.2 Droplets 
 
The water contact angle at the FAS-17 surface was as high as ≈115° and 
mineral oil type Sigma M5904 exhibited an angle of ≈65°. These hydrophobic 
and oilophobic properties ensured that both liquids did not spread around and 
stayed where we dispensed them. The water-based sample was pipetted into 
an oil droplet with typically volume 100× smaller than that of the sample. 
Surface tension of both liquids with their ratio of 100:1 resulted in self-aligned 
system with the water sample covered with a layer of oil. The cross section 
through the water-based sample in a VCR-PCR system is shown in Figure 31 
where the ratio is 1:3 (sample:oil). On Figure 32 we can see the higher contact 
angle with the ratio 100:1 
 
Figure 31: VCR used for a miniaturized PCR device (Neuzil et al, 2006): 2 
droplets, one sample droplet (PCR sample) within a mineral oil droplet on an 
hydrophobically coated glass surface. 
 
The stability of VRCs was tested in several contexts, having been used 
for superheating of spores[263], peptides[253], sample preparation[272] and PCR 
[256-259, 273-274] among, possibly, others. 
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Figure 32: Profile photo on the left of a water droplet on an hydrophobically 
coated (FAS-17) glass cover slide.exhibiting a contact angle of 104º, and on the 
right, of a VRC with ratio of water-sample:oil-layer of 100:1, giving a contact 
angle of 94º on the same hydrophobically coated (FAS-17) glass cover slide. 
 
6.3 XYZ stage 
 
Initially, a manual way of magnetically actuating the VRCs was designed. A 
xy-translation microscope stage was adapted to a holder, together with a z-
translation platform. A magnet was fixed to this z-translation platform in order to 
test the magnetic actuation of the droplets spotted on the glass slide placed in 
the center and on top of the xy-translation stage. In order to move the xy-
translation stage, a ratchet-style system was implemented to move the magnet 
in increments of 3 mm both on x- and on y-axis. (Figure 33 and Figure 34) 
 
 
Figure 33: Microscope translation stage on “homemade” setup. The 
microscope xy-translation stage is fixed. A precision z-translation platform is 
coupled underneath and a magnet is attached to its centre. A glass slide is 
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placed on top and on the centre of the xy-translation stage, having the magnet 
placed just beneath. 
 
 
Figure 34: Manual, incremental steps using ratchet-style system; 3 mm steps 
for forward/backward, and left/right motions.  
A disc (1/8 in.) neodymium magnet (no. B421, Supermagnetic.de) was 
placed 0,6 mm beneath the glass slide, with vertical alignment. This model was 
chosen due to the combination of ability of focusing the particles through the 
glass slide thickness and availability in the lab. 
After the magnetic actuation was concluded and the decision on the magnet 
to use was done, there was a need to exchange the manual xyz stage for an 
automatic (the movement and positioning of the magnet must be more flexible, 
smooth and not done in increments, rather on a continuous movement) (Figure 
35). 
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Figure 35: Photograph of the entire set up, where a) corresponds to the 
motorized xyz-stage placed in a black box, b) illustrates the PMT placed on top 
od the xyz-motorized stage for detection, c) the software to program the xyz-
motorized stage, d) the pre-amplifier for the secondary photodiode that works 
as control to the PMT (placed underneath the glass slide.), and e) the recording 
oscilloscope. 
 
6.4 Detection system 
 
Luminescent detection was tested and achieved using a 1x1 cm photodiode 
placed underneath the glass slide, on top of the z-translation stage with the 
magnet attached to it, and a photon-counting photomultiplier tube (PMT) 
module (H7155, Hamamatsu, Japan) placed on top of the glass slide holder. 
Both the photodiode and the PMT were connected to a current amplifier, and 
the signal was recorded with an oscilloscope. Thus, all reactions were 
conducted at the sample location with respect to the PMT. With this setup, both 
the magnet and the PMT were stationary while the glass was movable. The 
stage with the PMT and magnet was placed in a black box to eliminate ambient 
light noise. The PMT was equipped with an internal current-to voltage converter, 
with its gain adjusted to ?0.7 V using a custom made PMT controller setting the 
gain value to ?105 as interpolated from a graph supplied by the manufacturer. 
The PMT output was directly connected to the input of an oscilloscope model 
DPO 7054 provided by Tektronix, Inc. (USA) to record optical power as a 
function of time (Figure 35). 
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6.5 SPP/ssDNA/primer complex preparation 
 
For pyrosequencing, ?100 μL of superparamagnetic particles M280 
Dynabeads functionalized with streptavidin from Life Technologies, GmbH 
(Germany) was washed three consecutive times and re-suspended in 100 μL of 
binding buffer (10 mM Tris buffer pH 7.6, 2 M NaCl, 1 mM EDTA solution and 
0.1% Tween 20). All products were acquired from by Sigma-Aldrich, GmbH 
(Germany).  
DNA has to be extracted from the sample organism/solution, purified, 
and amplified by PCR, all prior to pyrosequencing.  
An amount of circa 4 μg of biotinylated PCR amplicon suspended in 100 
μL of H2O were added to the superparamagnetic particles and incubated at 65 
°C for 15 min with intermittent mixing for allowing the DNA binding. The double-
stranded amplicon was denatured by adding the superparamagnetic particles to 
denaturation buffer (100 μL of 0.5 M NaOH for 1 min). The superparamagnetic 
particles were then washed with NaOH followed by three additional washing 
steps in annealing buffer (20 mM Tris acetate, pH 7.6, 5 mM magnesium 
acetate) to obtain ssDNA. The superparamagnetic particles were re-suspended 
in 100 μL of annealing buffer before adding 5 μL of 10 μM sequencing primer 
for hybridization of the primer. The solution was heated to 80°C for 2 min using 
a heating block and let cool down to room temperature for the primer to 
hybridize. The SPP/ssDNA/primer complex was washed three times in 
pyrosequencing wash buffer as described in section 6.6. Afterwards, 15 μg of 
single-stranded binding protein (SSB) by Promega, GmbH (Germany) was 
added and the mixture incubated at room temperature for 10 min. The 
SPP/ssDNA/primer complex was washed with pyrosequencing wash buffer and 
re-suspended in 200 μL of this same buffer to achieve a final particle mass 
concentration of circa 5 μg μL?1. Considering the manufacturer's given specified 
binding capacity for the SPPs, it was estimated that the 5 μL aliquot used in 
each sequencing reaction contained between 100 and 500 pmol of template 
DNA.  
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6.6 Buffers and solutions preparation 
 
Distinct stock solutions were prepared for performing pyrosequencing: 
washing buffer, enzymes, dNTPs, and DNA. Pyrosequencing washing buffer 
was prepared by adding 100 mM Tris acetate pH 7.6 with 0.5 mM 
ethylenediaminetetraacetic acid (EDTA) pH 8.0, 5 mM magnesium acetate, and 
0.01% Tween 20. Enzymatic aliquots were prepared with pyrosequencing 
washing buffer by adding 13.5 mU μL?1 ATP sulfurylase by New England 
BioLabs Inc. (Germany), 1.5 μg μL?1 luciferase and 1.8 μg μL?1 D-luciferin by 
Sigma-Aldrich, GmbH (Germany), 6.9 U μL?1 Klenow (exo-) fragment by 
ThermoFisher Scientific, GmbH (Germany), and 0.01% Tween 20, 18 μM stock 
solutions of each dNTP by Thermoscientific, GmbH (Germany) were added to 
pyrosequencing washing buffer with 15 μM APS by Sigma-Aldrich (Germany), 3 
mM dithiothreitol (DTT) by Sigma-Aldrich, GmbH (Germany), 120 ng μL?1 single 
stranded binding protein (SSB), and 4.6 U μL?1 Klenow (exo-) fragment. 
 
6.7 Glass spotting 
 
The oil-coated and bead-containing droplets were placed on the 
hydrophobic surface of the substrate by precision-pipetting. In our experiments, 
the amount of surrounding oil layer, reaction or washing solutions and the 
SPPs/ssDNA/primer complex suspension were sequentially added, which 
spontaneously formed the droplets. Firstly, the suspended SPP/ssDNA/primer 
complex in the aqueous droplet is attracted to the bottom of the droplet by the 
magnetic force from the permanent magnet placed below. When the magnet is 
moved horizontally and parallel to the glass substrate, the SPPs follow the 
magnet until they reach the edge of the aqueous droplet, where they form a 
compact cluster. Secondly, the magnetic pulling force acting on the SPP-cluster 
is transferred to the water/oil interface and deforms the droplet. Thereafter, and 
as explained previously in section 3.3 two distinct operations were achieved: 
droplet transport for mixing reagents that need to be separated until the moment 
of reaction and SPP extraction for washing steps. 
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 With this in mind, a few different designs for spotting of the VRCs were 
tested. 
 
6.7.1 X-design 
 
Similarly to the pattern used before in a PCR platform (Figure 36) the 
initial idea for an experiment would be having 4 droplets containing all reagents 
needed for pyrosequencing and each one of the nucleotides on the chip with 
one droplet for washing in the center and make the magnetic particles move 
inwards and outwards to fulfil cycles of reaction and washing (Figures 37 and 
Figure 38). 
 
Figure 36: Sample preparation and PCR platform using VRC (Pipper et al, 
2008). 
 
 
Figure 37: Droplet-based pyrosequencing. (a) ssDNA bound to magnetic 
particles is pulled into the first nucleotide droplet (dATP) where (b) dATP is 
incorporated and light is emitted. The particles are then (c) washed, and (d) 
dragged into the dTTP droplet, where (e) no light is produced, hence dTTP is 
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not incorporated. The procedure continues to the remaining droplets completing 
one cycle. The cycle is repeated until no more light is detected (end of 
sequencing or depletion of reagents). 
 
 
Figure 38: Photograph of the setup, showing the central wash droplet and the 
four nucleotide droplets around it a) side view, b) top view. The magnet can be 
seen underneath the glass slide. The glass slide was moved via a motorized 
translation stage, while the magnet was fixed in position. A PMT was used for 
detection and all reactions took place inside a black box. The particles can be 
seen as a brown pallet on top of the glass actuated by the magnet beneath it. 
 
6.7.2 Circle/linear design 
 
If contamination would be evident than a washing step before each 
reaction droplet could be added (Figure 39). 
 
Figure 39: Droplet-based pyrosequencing. ssDNA bound to magnetic particles 
is pulled into the first nucleotide droplet (dATP) where dATP is incorporated and 
light is emitted. The particles are then washed, and dragged into the dTTP 
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droplet, where no light is produced, hence dTTP is not incorporated. The 
procedure continues to the remaining droplets completing one cycle. The cycle 
is repeated until no more light is detected (end of sequencing or depletion of 
reagents) and the motion happens in a circular movement of the magnet. In 
comparison with the previous design (Figure 37) there are more washing 
stations present in order to reduce contamination issues. 
 
6.7.3 Enzymes separated from substrate design 
 
 For this design, the enzymes needed for pyrosequencing are separated 
from the substrates in different droplets. These two smaller droplets (3 and 2 µL 
respectively) are merged only when the SPP/ssDNA/primer complex moves and 
drags them into the space between them. 
 
Figure 40: (A) Scheme of a nucleotide addition cycle.(a–c) Three phases of the 
droplet manipulation being a) extraction from SPP from washing droplet and 
moving to reaction station, b) merging of enzyme and substrate droplets and c) 
extraction of SPP towards a fresh washing droplet. (B) Overview of the 
experiment setup; (W) washing droplets; (E) droplets containing all the needed 
enzymes for the pyrosequencing reaction (S + G ? T ? C ? A).  
 
6.8 DNA preparation 
 
Preceding the sequencing, DNA has to be extracted from the sample, 
purified, and amplified by PCR.  
The DNA used for de novo sequencing was prepared by nested PCR for 
biotinylation of the amplicon (221 bps long). A section from the pfcrt 271 region 
from human genomic DNA was picked. (Primers: external forward: 5’-GGC TAT 
GGT ATC CTT TTT CCA A-3’; external reverse: 5’-CGA CTG TGT TTC TTC 
CCA AG-3’; internal forward: B-5’-ATC CTT TTT CCA ATT GTT CAC TTC-3’; 
and internal reverse: 5’-CGA AAC CAT TTT TTA TAT TTG TCC-3’.) 
Sequencing was carried out with the sequencing primer 5’-TTT CCT AAT TAA 
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TTC TTA CG-3’. The amplification was carried out in a LightCycler®1.0 System 
(Roche, Switzerland) and a SYBR Green based kit compatible with the system. 
 
The sequence B-5‘-ATG GGG GGG GGG ATG GGG GGG GGA TGG 
GGG GGA TGG GGG GGA TTG GGG GGT TGG GGG ATG GGG TCT GGT 
ATG GAT GTA AAC GCC TGG TAT CTT TAT AGT CCA-3‘ was  assessed with 
the sequencing-primer 5‘-GGA CTA TAA AGA TAC CAG GCG TT-3’ using the 
concentrations of DNA 0.315 pmol, 1.25 pmol, 5,pmol, 15 pmol and 20 pmol. 
 
 The sequence B-5‘-ATG GGG GGG GGG ATG GGG GGG GGA TGG 
GGG GGG ATG GGG GGG ATT GGG GGG TTG GGG GAT GGG GTC TGG 
TAT GGA TGT AAA CGC CTG GTA TCT TTA TAG TCC A-3‘ was assessed 
with the sequencing-primer 5‘-GGA CTA TAA AGA TAC CAG GCG TT-3’. 
 
The resulting PCR product was cleaned with the PureLink® PCR 
Purification Kit (ThermoFisher Scientific, Germany) and the biotinylation was 
checked with the Agilent Bioanalyzer 2100 (Agilent, Germany) together with the 
DNA 12000 Kit following standard protocols. 
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Chapter 7 
 
Results and discussion 
 
The aim of this thesis, as has been stated in the preceding chapters, is to 
explore miniaturized technologies for sequencing nucleic acids and detecting 
single-base variations. The study involves the design and microfabrication of a 
microfluidic platform with attention being given to the biological compatibility of 
the process and the evaluation of the biological assays. A microfluidic approach 
based on virtual chamber reactions (and magnetic actuation is evaluated to 
handle nucleic acids. The feasibility of adapting pyrosequencing to a 
microfluidic platform was also investigated and a novel approach involving on-
chip bead-based DNA analysis is was developed for DNA sequencing and SNP 
detection. 
This chapter is meant to report and discuss all relevant results obtained 
on the pursuit of the goals above mentioned. 
 
DISCLAIMER: The results presented on this thesis are published in 
Open Access format (A. V. Almeida, A. Manz, P. Neuzil, Lab on a Chip 
2016, 16, 1063-1071) [264], with the knowledge and permission of co-
authors and publisher, Royal Society of Chemistry. 
 
7.1 Experimental design 
 
 The basic experimental idea can be represented by the workflow 
presented in Figure 41. The first step (experimental design) comprises the 
knowledge of the nucleic acid sequence to be analyzed and arranging all 
resources needed.  
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Figure 41: Diagram expressing the workflow from experimental design to 
sequencing step. Design stands for experimental design and comprehends all 
thought processes leading to have all the correct PCR and sequencing primers, 
adjusting of reagents, preparation of the glass slide and programming the 
motorized stage. The PCR is used for biotinylation of the DNA and to make the 
sequences more manageable and pure. The check involves the PCR product 
purification and the confirmation of its purity by Bioanalyzer. The last two stages 
correspond to the preparation of the VRCs responsible for washing and reaction 
stations and to perform the magnetic actuation of the system. 
 
Then, the DNA to be sequenced must be extracted, prepared and 
checked for biotinylation and purity as mentioned in subchapter 6.8 (Figure 
42). This ssDNA must then be bound to streptavidin coated paramagnetic 
particles via biotin-streptavidin bond. The sequencing primer must as well be 
annealed after this point as described in subchapter 6.5 (Figure 43). 
 
 
Figure 42: On top of the figure, the target-sequence is analyzed according to 
the required primers and where the biotinylation should occur (marked by the 
red circle). Red nucleotides and underlining show positions of internal and 
external primers used in the nested. In a) we can see the result on the qPCR, 
beinfg the highest peak correspondent to the desired product (desired 
sequenced to test the sequencing on). b) After proceeding to purification of the 
product(to remove the enzymes, excess of primers and other byproducts, the 
purified and desired sequence in analyzed for biotinylation success using the 
Bioanalyzer and the corresponding kit. 
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Figure 43: Biotinylated DNA from is obtained by PCR and then bound to 
streptavidine-functionalized superparamagnetic particles. Further washing and 
incubating steps are perfomed until an amount of 0.25-0.5 pmol of template per 
µL of paticles is achieved. The exact composition of the buffers and procedures 
are described in the table. 
 
7.2 First experiments 
Finally, the VRCs must be placed on the flat hydrophobically coated 
glass substrate in a pre-determined position and the paramagnetic particles can 
then be actuated using the xyz-translation stage (Figure 44). 
 
Figure 44: Scheme and photograph of the setup, showing the central wash 
droplet and the four nucleotide droplets around it. The magnet can be seen 
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underneath the glass slide. The hydrophobic glass slide is moved via a 
motorized translation stage, while the magnet is fixed in position. A PMT is used 
for detection and all reactions took place inside a black box. Five droplets are 
spotted in a cross pattern onto the cover slip): a large central droplet (60 µL) 
containing only washing solution, and four droplets (20 µL) arranged around it 
containing one of the nucleotides together with the necessary pyrosequencing 
enzymes. The droplets are each sealed in a layer of mineral oil to prevent 
evaporation. On the photograph, the paramagnetic particles can be seen in the 
washing droplet forming a brown coloured pellet on top of the magnet. 
 To test the detection system before performing pyrosequencing and 
wasting reagents, luciferin and luciferase were mixed with ATP (the needed 
substrate for the luciferin to be oxidized by the luciferase with release of 
photons, refer to subchapter 1.3.4 for more details). An intense and sharp peak 
was easily detected using the prepared set up (Figure 45) meaning the 
detection system is sensitive enough for the goal of this project. 
 
Figure 45: Plot derived from the detection system. Mixture of ATP, luciferin and 
luciferase produced photons that could be easily be detected by the photodiode 
from the set up. The signal was recorded in intensity (mV) over time (seconds). 
 In order to see if the motion of the motorized stage for magnetic actuation 
would interfere with the detection system, a simple program mimicking the 
magnetic actuation through the reaction and the washing VRCs was 
programmed. As seen in Figure 46, in fact the motion of the stage can be 
detected and it follows a pattern (as expected since the program selected 
follows the same movement between 5 different droplets for a number of cycles. 
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Figure 46: Background noise 
detected with a run of the 
motorized stage performed 
without reagents. Here; the 
pattern of the repeated cycles of 
the same movements 
combination can be easily 
observed.  
 
 
 
After the background noise derived from the inevitable motorized stage 
motion was determined, the first try for pyrosequencing using the cross design 
for VRC spotting was performed. Figure 47 shows the same pattern obtained 
for the background check. However, a wide, single peak was detected. As the 
“peak” occurs, the noise becomes more prominent making it difficult for 
extraction of the background or further interpretation. Nevertheless, more time 
was given for the particles to be in a droplet (both reaction and washing) in 
order to evaluate differences to the initial try and the results can be seen in 
Figure 48. 
 
Figure 47: Failed pyrogram showing the motion pattern with a wide peak not 
corresponding to the reaction droplets. Almost like a single reaction event. The 
motion noise seems to be sharper within this ”peak” which makes difficult for 
background noise removal.  
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Figure 48: Failed pyrogram showing the same motion pattern with a wide peak 
not corresponding to the reaction droplets. With more time in a specific droplet it 
is more obvious the pattern to be related with the stage motion and not from 
light detection. 
 A longer time for reaction was tested as well and is summarized in 
Figure 49. 
 
Figure 49: a) GCTA; b) AGTC and c) ATGC are all tries of sequencing using a 
longer reaction time. And d) is the corresponding blank. 
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 At this stage it was obvious that major changes and improvement was 
needed. and main priorities were established: 
- Test different VRC spotting patterns. 
- Optimizing the ratio between beads – DNA - droplet size – droplet 
distance (kinetics evaluation). 
- Investigate Z influence on particles dispersion.  
- Test washing efficiency. 
- Demonstrate the technique feasibility by detecting a known sequence 
7.3 VRCs placement 
For testing different VRC spotting designs, the 5 droplet system was put 
aside and in order to have more flexibility of rearrangement the 2x2cm glass 
slide format was substituted by the 2x6 cm format (Figure 50). As well, washing 
efficiency was tested to see if there was any carry over/contamination by the 
SPP. 
Figure 50: a) was the one tested, the b) is the same as the circle design but 
this in linear form which gives more possibilities of cycling more often with fresh 
washing droplets (refer to circle design on subchapter 4.7.2. c) represents a 
design for incorporation two washing droplets between two reaction. 
 
 By using single-use VRCs and extending further the time for each 
reaction to happen, the first expected peaks started to appear. Two different 
testes, being one having all reagents, with all 4 nucleotides and the complex 
SPP/ssDNA/primer letting to react until reaching baseline, and the other all 
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reagents without the complex SPP/ssDNA/primer letting to react until reaching 
baseline as well, were carried out (Figure 51). From this, it was confirmed that 
whenever substrates and enzymes are together in solution there is always a 
background reaction. Either the entire sequencing should happen in this window 
or substartes and enzymes should be kept separated until needed. 
 
Figure 51: a) was having both reaction and washing VRCs beingsingle-used 
having each reaction last for 500 sec. b) was having all reagents with all 4 
nucleotides and SPP/DNA/primer complex simulatenously; c) having all 
reagents without the SPP/DNA/primer complex. 
 
 In case of the first option, some success was achieved (Figure 52) but 
the peaks still didn’t show the typical curve. 
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Figure 52: Success 1 with incorporation of better washing…still don’t see 
curves and there is still a decrese of signal over time 
 
7.4 Optimization of reagents and buffers  
In order to optimize the reaction, an optimization of the content of the 
buffers (particularly in regards to oil:sample ratio and Tween in order to improve 
the surface tension of the VRCs to allow removing of the SPP complex from the 
droplets without and with dragging as wished) was carried out. (Figure 53) 
 
Figure 53: Effect of oil loading on dynamic droplet shape (a) and of Tween 
content (b). The white arrows refer to the transport direction. The volume of the 
aqueous phase was 5 µL in all cases. A stock suspension (~20 µg/µL) of 0.5 
µm diameter SiMAG particles was used for the test. 
 
 Due to this, another spotting design was tested where the reaction VRCs 
were divided into two VRCs, one containing the substrates and the other one 
containing the enzymes, both needed for the pyrosequencing chemistry (Figure 
54). With the movement of the complex SPP/ssDNA/primer these two smaller 
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VRCs would merge and the background reaction and reagents depletion 
wouldn’t occur before time (Figure 55). 
 
Figure 54: Photograph of the prepared spotted glass. On a) the overall view with the 
SPP complex being located on the top left washing droplet. b) the first stage of the 
motion. c), d) and e) the SPP complex finds its way via magnetic actuation to the first 
enzyme droplet. In f) the enzyme droplet merges with the substrate droplet. g) The 
SPP complex will move to the next washing station h). and to merge the next enzyme 
and substrate VRCs in i) and j). 
 
 
Figure 55: Pyrogram showing the order of in which the magnetic particles were pulled 
into each nucleotide droplet (lower axis), and the order in which the nucleotides were 
successfully incorporated into the DNA chain (upper axis), yielding the final nucleotide 
sequence. DNA was sequenced with a read-length of 7 bp which corresponds to first 
success. 
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7.5 Washing efficiency 
 
Additionally, an initial series of experiments with the presence and the 
absence of a washing step was carried out. Conducting the pyrosequencing 
nucleotide additions without the washing step resulted in a 30% carry-over 
signal caused by the DNA/primer/SPP complex. Once the washing step was 
included, the carry-over signal was eliminated (Figure 56); therefore, each 
nucleotide addition reaction was followed with a single washing step. As one 
can see from Figure 56, once the washing step was included into the 
experiment design, no photons were detected from the sample, which indicates 
no significant amount of chemicals were carried over. 
 
 
Figure 56: Washing efficiency. SPP were moved between two droplets, one 
containing inorganic pyrophosphate (PPi), and the other enzymes and 
substrates used for pyrosequencing while the luminescence was continuously 
monitored by PMT and recorded by an oscilloscope. a) We have merged both, 
b) extracted the SSP from one droplet to the next and c) included a washing 
step between. Results demonstrated that efficiency of using a washing step 
successfully canceled the signal coming from cross-contamination. Peak 
amplitude (minus baseline subtraction) dropped from around 4V to around 1.5V 
and to practically 0V once the washing step was included.  
 
7.6 Mixing improvement 
 
For each experiment, fresh superhydrophobic glass cover slips were 
used to remove possibility of sample-to-sample cross contamination, which is a 
benefit of disposable and microfabrication-free platform. The diffusion-
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dependent rate of the pyrosequencing process was improved upon by moving 
the SPPs within the droplet during the reaction for active mixing. The stage 
moved by ±?2 mm along both X and Y axes at the speed of ?2 mm s?1, which 
reduced the reaction time by a factor of almost 2 (Figure 57).  
 
Figure 57 SPP/primer/DNA complex was moved within droplets with enzymes, 
substrates and dNTP whilst monitoring with a PMT and recording with an 
oscilloscope the resulting luminescence. The resulting luminescence was both 
recorded while having the magnet static in position (black squares) and moving 
in the reaction droplet with speed of ≈2 mm/s (red circles). This Figure can be 
found in the supplementary information of Almeida et al. (2015) [264] and it was 
reproduced with permission of Royal Society of Chemistry. 
 
Initially, the signal peak amplitude was 1.00 V and its area was 0.32 mC. 
Stimulated by stirring, the peak amplitude increased to 1.99 V and the area 
dropped to 0.27 mC. The AUC amplitude dropped to 85% of its original value 
while the signal peak amplitude increased by factor of 2. The signal reached the 
baseline amplitude at time 275 seconds; thus, we decided that keeping the 
reaction under the PMT for 300 seconds should be sufficient. Next, we 
performed a set of experiments to determine optimum DNA quantity.  
 
7.7. Effect of DNA concentration 
 
55 μg of SPPs were used in combination with DNA concentrations from 
0.3125 pmol to 20 pmol. The DNA concentration of 1.25 pmol seemed to be 
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optimal considering the lowest amount possible to use in order to have a 
detectable difference between. 
The sequence B-5‘-ATG GGG GGG GGG ATG GGG GGG GGAT GGG 
GGG GGA TGG GGG GGA TTG GGG GGT TGG GGG ATG GGG TCT GGT 
ATG GAT GTA AAC GCC TGG TAT CTT TAT AGT CCA-3‘ was assessed 
using the sequencing-primer 5‘-GGA CTA TAA AGA TAC CAG GCG TT-3’ with 
different concentrations of DNA, such as 0.315 pmol (Figure 58), 1.25 pmol 
(Figure 59a), 5,pmol (Figure 59b), 15 pmol (Figure 59c) and 20 pmol. (Figure 
60). 
 
Figure 58. Effectiveness of using concentration of 0,315 pmol DNA on SPPs for 
pyrosequencing on OSM. (A) Pyrogram consisting of 38 reactions performed on 
3 glasses with two changes marked by peaks around 15th and 30th reactions. 
(B) Extracted peak voltages (mean value) with standard error as function of 
reaction number from three measurements to compare with (C) extracted AUC 
(mean value) with standard error as function of reaction number from three 
measurements. Figure present in Almeida et al (2015) and reproduced with 
permission of Royal Society of Chemistry. [264] 
 
By using 0,315 pmol DNA, there was practically no difference between 
background reaction noise and the luminescence detected from the 
incorporation of 1 nucleotide by DNA molecule which makes it unsuitably low. 
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The same was carried out with the concentrations of 1.25 pmol (Figure 
59a), 5 pmol (Figure 59b), 15 pmol (Figure 59c) and 20 pmol (Figure 60). 
 
Figure 59. Effectiveness of using concentrations of 1.25 pmol (a), 5 pmol (b) 
and 15 pmol (c) with the peak amplitude (blue) and AUC (red) as function of 
number of incorporated nucleotides: a) with slope of (0.969 ± 0.227) V and 
(0.147 ± 0.021) mC, both (mean ± standard deviation) for peak voltage and 
AUC, respectively; the nonlinearity is significantly smaller than the one for 0.315 
pmol concentration of DNA with correlation coefficient of 0.959 and 0.896 for 
peak voltage and AUC, respectively; b) with slope of (6.478 ± 0. 242) V and 
(0.899 ± 0.025) mC, both (mean ± standard deviation) for peak voltage and 
AUC, respectively; the nonlinearity is even smaller than the one for 1.25 pmol 
concentration as the correlation coefficient is near unity, 0.997 and 0.998 for 
peak voltage and AUC, respectively;. c) with slope of (14.144 ± 0.099) V and 
(1.900 ± 0.005) mC, both (mean ± standard deviation) for peak voltage and 
AUC, respectively; the nonlinearity is even smaller than the one for 1.25 pmol 
concentration as the correlation coefficient is practically unity, 0.999 for 
both,peak voltage and the AUC. Adapted from figures published by Almeida et 
al. (2015). [264] 
 
The concentrations of 1,25 pmol, 5 pmol and 15 pmol (Figure 59) 
resulted in well-distinguished groups for each number of nucleotide 
incorporation. Even if the linearity increases with the concentration of DNA, the 
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1,25 pmol concentration results indicated efficient discernment between number 
of consecutive incorporations of nucleotides. 
When the concentration used was 20 pmol such distinction between the 
different numbers of consecutive nucleotide additions was non-existing for 
some reactions which makes this concentration unsuitable for the 
pyrosequencing purpose (Figure 60). 
 
 
Figure 60 Effectiveness of using concentration of 20 pmol DNA on SPPs for 
pyrosequencing on OSM (A) Pyrogram with 38 reactions carried out on 3 
glasses with transitions marked by detected luminescence peaks around 
reactions 15 and 30. (B) Peak voltages (mean value) with standard error as 
function of reaction number from single measurement. (C) AUCs (mean value) 
with standard deviation as function of reaction number from single 
measurement. Both (D) frequency count of mean peak values and (E) AUCs do 
not distinguish groups by number of incorporated nucleotides as lower 
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concentrations. Additionally, (F) peak amplitude (blue) and AUC (red) as 
function of number of incorporated nucleotides confirms that this DNA 
concentration is not suitable for pyrosequencing. Reproduced from Almeida et 
al. (2015) with permission of Royal Society of Chemistry.[264] 
 
With the 1,25 pmol concentration, the peak voltage and AUC amplitude 
were (0.969 ± 0.227) V and (0.147 ± 0.021) mC (mean ± standard deviation) 
per single nucleotide incorporation, respectively, with correlation coefficient of 
0.959 and 0.896 for peak voltage and AUC, respectively. This peak voltage 
signal was 100 times higher than the background noise while requiring 
minimum DNA consumption (Figure 61).  
 
 
Figure 61. Effectiveness of using concentration of 1,25 pmol DNA on SPPs for 
pyrosequencing on OSM (A) Pyrogram with 38 reactions carried out on 3 
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glasses with transitions marked by detected luminescence peaks around 
reactions 15 and 30. (B) Peak voltages (mean value) with standard error as 
function of reaction number from single measurement. (C) AUCs (mean value) 
with standard deviation as function of reaction number from single 
measurement. Both (D) frequency count of mean peak values and (E) AUCs do 
not distinguish groups by number of incorporated nucleotides as lower 
concentrations. Additionally, (F) peak amplitude (blue) and AUC (red) as 
function of number of incorporated nucleotides confirms that this DNA 
concentration is not suitable for pyrosequencing. Reproduced from Almeida et 
al. (2015) with permission of Royal Society of Chemistry. [264] 
 
As previously mentioned, each glass cover slip can host up to one-use 
16 reaction stations (washing droplets + enzyme and substrate droplets). This 
means, sequencing more than 16 nucleotides will require many glass cover 
slips and the sample has to be transferred from one glass to the next glass. 
These unloading/loading stations were designed not to contain matching 
nucleotides, but just to be reference points to determine the background signal 
working as additional washing stations. The unloading was performed via 
pipetting with a magnet attached to the outside surface of the pippete tip and 
the loading by detaching this same magnet. After completion of the 
experiments, both the AUC and peak voltage amplitudes were calculated from 5 
transfers in unloading and loading stations and compared. The loading PMT 
peak and AUC amplitude were (0.79 ± 0.08) V and (0.094 ± 0.005) mC (mean ± 
standard deviation), respectively. Unloading PMT and AUC amplitude were 
(0.79 ± 0.11) V and (0.098 ± 0.014) mC (mean ± standard deviation), 
respectively. The results during loading and unloading are very similar, 
demonstrating the transfer efficiency which assures that the SPP/prime/ssDNA 
complex can be transferred while keeping the same amplitude of emitted photos 
during DNA sequencing.  
 
7.8 Nucleotide incorporation in homopolymeric stretches 
 
The maximum number of homopolymeric nucleotide additions per single 
incorporation possible to assess on this platform were also studied (Figure 62). 
This was done by using the sequence B-5‘-ATG GGG GGG GGG ATG GGG 
GGG GGA TGG GGG GGG ATG GGG GGG ATT GGG GGG TTG GGG GAT 
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GGG GTC TGG TAT GGA TGT AAA CGC CTG GTA TCT TTA TAG TCC A-3‘ 
in combination with the sequencing-primer 5‘-GGA CTA TAA AGA TAC CAG 
GCG TT-3’. This was meant to investigate the limits of the platform by 
assessing extreme cases such as 10 identical nucleotides in succession. 
 
 
 
Figure 62: (A) Pyrogram showcasing 55 reactions performed on 4 glasses with 
three changes marked by high intensity peaks around 17th, 34th and 48th 
reactions. (B) Peak voltages (mean value) with standard error as function of 
reaction number from two measurements. (C) AUC (value) with standard error 
as function of reaction number from two measurements. (D) Frequency count of 
mean peak values manifesting grouping by number of incorporated nucleotides 
from 0 up to 7 (highlighted by a black arrow). 10 identical incorporated 
nucleotides in a row results are highlighted with a red circle. (E) Frequency 
count of mean AUC manifesting grouping according to number of incorporated 
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nucleotides from 0 up to 5 showing that the peak values give more consistent 
data. (F) Peak amplitude (blue) and AUC (red) as function of number of 
incorporated nucleotides. This has proven that the OSM-sequencing can be 
used for up to 7 identical serial nucleotides with (1.354 ±0.075) V (mean ± 
standard deviation) per incorporated nucleotide. Reproduced from Almeida et 
al. (2015) with permission of Royal Society of Chemistry.[264] 
 
The amplitude of emitted light starts was observed to drop after 
incorporations of more than seven identical nucleotides in a row. Both peak 
voltages and AUCs amplitude were determined with (1.451 ± 0.067) V and 
(0.175 ± 0.020) mC (mean ± standard deviation), respectively, per single 
nucleotide incorporation. Peak voltage amplitude showed more consistent data 
than the AUC amplitude. The signal level after each wash cycle could be 
reduced in the reaction complex due to loss or denaturation of either the DNA 
template or the sequencing primer. 
 
7.9 Resequencing 
 
The platform and experimental design were tested with DNA 
concentration of 1.25 pmol with a re-sequencing experiment (Figure 63). A 
hydrophobic glass cover slip was prepared with the dNTPs placed in pre-
determined order, corresponding to the complementary DNA strand, a 34-mer. 
The sequence consisted of 21 single, 3 double, 1 triple, and 1 quadruple 
nucleotide incorporations, and 4 mismatches. We had to use two glass cover 
slips with one sample transfer from the first glass to the second glass. This 
system enabled monitoring the emitted photons of the known nucleotide 
incorporations and to determine the reaction stability as well as reproducibility 
as displayed in Figure 63A. The DNA/primer/SPP complex was moved into a 
washing droplet in the end of the experiment. The resequencing was performed 
five times to eliminate random errors and to demonstrate repeatability (error 
bars in Figure 63B). A mismatched event was performed during the sample 
loading and unloading to determine the background emission as highlighted by 
the blue ellipses (Figure 63C). It was shown that both peak voltages and AUCs 
amplitude can be utilized for determination of the number of incorporated 
nucleotides (Figure 63D and E, each containing five groups separated from 
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others). The PMT peak voltage and AUC amplitude are linearly proportional to 
the number of incorporated nucleotides which demonstrates feasibility of the 
method as well as little or no loss of SPP, DNA, or primer (Figure 63F). The 
background peak voltage value and AUC amplitudes were only (0.799 ± 0.079) 
AUC and (0.010 ± 0.012) mC (mean ± standard deviation), respectively, well 
below the signal for single nucleotide incorporation. The order of reaction 
stations for resequencing is designed to match the sequence and incorporate 
nucleotides) in each reaction. Presence of a single nucleotide polymorphism 
(SNP) is detected as a missing reaction and there will be no nucleotide 
incorporation once the SNP occurs. The first and last reactions at each glass 
surface are performed with mismatched nucleotides during sample transfer to 
detect a background signal and calibrate the system. Once there is a nucleotide 
mismatch detected during resequencing, the signal will be either stronger than 
expected (in the case of incorporation of an identical nucleotide), or as intense 
as the background signal with no incorporation. In the latter case, the 
pyrosequencing would stop at this point but the user would know that there is at 
least one SNP in the tested sequence. 
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Figure 63 (A) Pyrogram from the resequencing. (B) Mean value of peak voltage 
and its standard error as function of reaction number. A mismatched event was 
performed in the end of the run to determine the background emission (marked 
by blue ellipses). (C) Mean value of AUC and its standard error as the function 
of the reaction. Frequency counts of average peak values (D) and AUCs (E) 
distinguish five groups according to the number of incorporated nucleotides with 
a nearly perfect linear relationship. (F) Peak amplitude (blue circles) and AUC 
(red triangles) as a function of the number of incorporated nucleotides with 
slope of (1.657 ± 0.140) V and (0.214 ± 0.026) mC for peak voltage and AUC, 
respectively. The nonlinearity is small as the correlation coefficients are 0.972 
and 0.944 for peak voltage and AUC, respectively. Reproduced from Almeida et 
al. (2015) with permission of Royal Society of Chemistry.[264] 
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7.10 de novo sequencing 
 
Proving the feasibility of OSM-sequencing method with unknown 
samples was carried out by performing de novo sequencing with a DNA 
template with the length of 51 bps. The sequence consisted of 16 single, 9 
double, 2 triple, 1 quadruple, and 1 quintuple nucleotide incorporations, and 30 
mismatches. We performed the experiment with four nucleotides added in a 
repeated cyclical fashion comprehending in total 70 reaction stations. The 
experimental apparatus involved five glass cover slips (Figure 64A) and times 
to avoid random errors. The detected emitted light was processed the same 
way as in the previous experiments (Figure 64B and C). In addition, histograms 
of both voltage and AUC values (Figure 64D) show better grouping for the peak 
voltage amplitude than that for AUCs (Figure 64E). The peak voltage 
amplitudes in each group (number of identical nucleotides incorporated in a 
row) are distinct from one another, which should enable an accurate sequence 
assessment of all 51 bases (Figure 64F). The value of peak voltage and AUC 
amplitude are (1.605 ± 0.068) V and (0.213 ± 0.021) mC (mean ± standard 
deviation), respectively. Again, the peak voltage signal shows better stability 
than the AUC as highlighted by the blue ellipse at Figure 64F, where the signal 
for the four identical incorporated nucleotides is practically identical to the one 
for three identical incorporated nucleotides which means the peak signal 
amplitude provides more consistent output than the one for AUC. 
 
 
 
 
 
 103 
 
 
Figure 64 (A) Pyrogram of de novo sequencing. (B) Mean value of peak voltage 
and its standard error as function of reaction number. A mismatched event was 
performed in the end of the run to determine the background emission (marked 
by blue ellipses). (C) Mean value of AUC and its standard error as function of 
reaction. Frequency counts of mean peak values (D) distinguish five groups 
according to the number of incorporated nucleotides and are better defined as 
AUC values (E) as seen with the blue ellipse marked in (F). (F) Peak amplitude 
(blue) is linearly proportional to the number of incorporated nucleotides with 
correlation coefficient of 0.991 and AUC (red) with the same coefficient of 
0.953. Reproduced from Almeida et al. (2015) with permission of Royal Society 
of Chemistry. [264] 
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7.11 Longer sequences testing 
 
Furthermore, a sequence with length of 81 nucleotides was carried out 
with a total of 104 reactions using de novo sequencing configuration. The 
sequence consisted of 35 single, 8 double, 4 triple, 2 quadruple, and 2 quintuple 
nucleotide incorporations, and 53 mismatches. The experiment required seven 
glass cover slips (Figure 65A). Peak voltage and AUC amplitudes were (1.495 
± 0.117) V and (0.182 ± 0.027) mC (mean ± standard deviation), respectively 
(Figure 65B and C). The signal per incorporated nucleotide is again well above 
the background of (0.794 ± 0.117) V and (0.102 ± 0.021) mC (mean ± standard 
deviation) for peak voltage and AUC amplitudes, respectively (Figure 65D). The 
OSM-sequencing since was able of 81 nucleotides incorporation and, as the 
PMT signal is has consistent amplitude per nucleotide incorporation, a greater 
number of nucleotide may be incorporated. The peak amplitude is linearly 
proportional to the number of incorporated nucleotides with correlation 
coefficient of 0.944. The same coefficient for AUC is 0.927. As seen before, 
peak voltage gives more consistent data than AUC (Figure 65E and F).  
Overall, it was seen that the peak voltage amplitude gave better data 
than AUC. The peak voltage amplitude per nucleotide incorporation varied 
between (1.354 ± 0.075) V, (1.657 ± 0.140) V, (1.605 ± 0.068) V and (1.339 ± 
0.145) V (mean ± standard deviation) homopolymeric stretches (Figure 61), re-
sequencing (Figure 62), de novo sequencing of 51 (Figure 63), and 81 
nucleotides (Figure 64), respectively. The differences are probably caused by 
variations in concentration of chemicals due to manual pipetting as well as 
temperature and humidity conditions fluctuation since most experiments were 
performed on different days. 
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Figure 65 (A) A pyrogram of long de novo sequencing with 104 reactions. (B) 
Extracted value of peak voltage as function of reaction number. (C) Extracted 
mean value of AUC as function of reaction number. Frequency counts of mean 
peak values (D) distinguish six groups according to the number of incorporated 
nucleotides. (E) Frequency counts of the AUC are not distinct (arrows). (F) 
Peak amplitude (blue) and AUC (red) as function of number of incorporated 
nucleotides. Reproduced from Almeida et al. (2015) with permission of Royal 
Society of Chemistry.[264] 
 
7.12 Comments on methods 
 
Prior to pyrosequencing, DNA has to be extracted from the sample, 
purified, and amplified by PCR. Most of these steps are either labor-intensive or 
require complex robotic systems. Except for pyrosequencing, all other 
necessary steps have been previously integrated using the OSM concept.[214-
215] The system proposed here is compatible with previous work, thus, it may be 
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included on into a single “sample-to-answer” platform. The pyrosequencing 
experiments were conducted on a glass cover slip as shown schematically in 
Figure 66. The ssDNA bound to SPP was placed into a first station as shown in 
(a), with a magnet underneath it. The particles are then dragged (b) using 
magnetic force into the first (E) enzyme-containing droplet. This droplet is close 
to the (S + Nt) substrate and nucleotide dNTP-containing droplet, that the 
droplets merge and the pyrosequencing reaction is triggered. The particles are 
then dragged into the washing droplet. This washing droplet is at a larger 
distance from the other droplets, so no merging of droplets occurs. The washing 
steps remove unincorporated or in excess nucleotides were designed which 
maximizes read length. The washing of SPP/template/primer complex allows 
removal of nucleotides as well as other reaction byproducts between nucleotide 
additions. Then, the particles are dragged into another reaction station (c) with 
two droplets, one with enzyme and the other one with substrate and another 
dNTP. A glass containing eight reaction stations is schematically shown in 
Figure 66B and a photograph of the setup with 16 stations in Figure 66C  as 
well as a transfer droplet containing DNA/primer/SPP. The droplets were 
colored with ink to increase the contrast. The glass with the dimension of 60×20 
mm and thickness of 170 μm was treated with 1H,1H,2H,2H-
perfluorodecyltriethoxysilane (FAS17), making the surface highly hydrophobic, 
with a water contact angle of 95°. The glass cover slip was placed on a 
computer controlled X–Y stage. A disc-shaped neodymium magnet with a 
diameter of 3 mm, model N45 mm by Supermagnetic, GmbH (Germany) was 
placed underneath the glass cover slip as previously described in Chapter 6. 
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Figure 66 (A) Representation of a typical nucleotide addition cycle. All droplets 
are covered with oil, thereby effectively preventing evaporation of water from 
the sample as well as reagent degradation by oxidation. (a–c) Three phases of 
pyrosequencing reaction. (B) Components of the experimental setup; (W) 
washing droplets; (E) droplets containing all the needed enzymes for the 
pyrosequencing reaction (S + dN). (C) Photograph of the setup consisting of the 
hydrophobically coated glass cover slip mounted onto a motorized X–Y 
translation stage with a neodymium–iron–boron magnet fixed beneath the cover 
slip. The droplets contained color ink to increase the contrast. Reproduced from 
Almeida et al. (2015) with permission of Royal Society of Chemistry.[264] 
 
The DNA/primer/SPP complex was on moved through the individual 
reaction/washing stations in the form of droplets using magnetic force. These 
“stations” were formed by pipetting individual droplets onto the glass covered 
with mineral oil, thereby preventing water evaporation from reaction droplets. 
After a series of experiments, the volumes of stations as well as oil covering 
them are summarized in Table 3. 
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Table 3. Ratio between oil and sample volumes stable up to 8 hours (initial and 
final volumes measured at 0, 2, 4, 6 and 8h) 
 Washing droplet Enzyme droplet 
Substrate and 
nucleotide droplet 
Droplet volume 
(µL) 
≈10 ≈3 ≈2 
Oil volume (µL) ≈2 ≈1 ≈1 
 
 A PMT was placed above the glass aligned with the magnet underneath. 
Since the sample was always attracted by the magnet and kept on the glass 
above it, it was also directly below the PMT; thus, all reactions were conducted 
at the sample location relatively to the PMT. With this setup, both the magnet 
and the PMT were stationary while the glass was the moving component. The 
stage with the PMT and magnet was placed in a black box to eliminate ambient 
light noise. All light emission was recorded and peaks were identified and 
individually processed to obtain the values of maximum amplitude as well as 
their areas under the curve (AUC). The AUC unit corresponds to the electrical 
charge C, as it is time integration of electrical current i from 0 s to t s: 
 !"# $ const % &d'
 
!
, 
where const is a conversion factor. It consists of a gain of PMT and its 
transconductance amplifier and PMT efficiency of 105, 1 μA V?1, and 85 mA W?
1, respectively for light wavelength of 550 nm. 
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Chapter 8 
 
Conclusions and outlook 
 
Referring to the objectives of this thesis defined on subchapter 4.2. 
 
5. To study the potential of droplets as virtual reaction chambers for nucleic 
acids handling. 
 
a) The potential of droplets as virtual reaction chambers for nucleic acids 
handling was investigated and confirmed. For this, the droplets were 
covered with mineral oil, thereby forming virtual reaction chambers. An 
oil layer was able to efficiently suppress water evaporation from the 
sample up to 8 hours of deposition on the glass substrate. (Table 3) 
 
b) Magnetic actuation was successful with DNA loaded superparamagnetic 
particles, meaning the DNA molecules could be manipulated within and 
between the virtual reaction chambers without significant degradation. 
Optical detection was used to make sure the particles aren’t being left 
behind or trapped by adjusting the speed and the trajectory of the 
magnet. (Figure 55) 
 
c) Was possible to move the particles within fixed droplets and to move the 
particles with the droplets making possible to merge droplets. (Figure 
56) 
 
6. To investigate virtual reaction chambers as a platform for pyrosequencing 
chemistry. 
 
a) The usage of only one washing station was considered sufficient and the 
active mixing by moving the particles in a VRC increased the speed of 
reaction in comparison with just diffusion based mixing. (Figures 58 and 
59) 
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7. To investigate the VRC based pyrosequencing platform for DNA 
sequencing. 
 
a) DNA sequencing was achieved using pyrosequencing chemistry. The 
pyrosequencing was performed by having reagents separated in different 
virtual reaction chambers and moving DNA molecules bound to 
superparamagnetic particles from droplet to droplet (washing and 
nucleotide addition) or dragging the droplets for droplet merging 
(enzymes and substrates real-time mixing). This platform successful 
determined up to 81 nucleotides long DNA sequences (Figure 68) 
(minimal degradation meaning with discernment of homolorymeric 
sections).  
 
b) The effect of DNA concentration bound to articles was tested and the 1.25 
pmol of DNA was revealed as the ideal one for DNA loading on the SPP 
(Figure 61). 
 
c) Base calling in the homopolymeric stretches was studied (u to 6 identical 
subsequent units) (Figure 65) 
 
8. To devise and test the platform for single nucleotide polymorphism analysis 
which was successful 
 
a) Single nucleotide polymorphisms were detected within the 55 nucleotide 
lenght from point 2. (Figure 66) 
 
9. Provide scope and perspective for the research trajectory towards more 
efficient and stable low cost and simple sequencing platforms. 
 
We have demonstrated a simple pyrosequencing system for both de novo 
(DNA sequencing) and re-sequencing (suitable for SNP detection) using open 
surface microfluidics with magnetic force actuation on a microscope glass cover 
slip surface without any surface patterning. Future improvements include an 
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automated pipetting station followed by a lyophilization step also would make 
this method more user friendly as operators would only require to dispense an 
appropriate amount of de-ionized water at pre-defined reaction and washing 
locations and cover those droplets with mineral oil. The system presented here 
is compatible with previously designed PCR as well as sample preparation 
systems. In future, one could create a single complex sample-to-answer system 
starting with a raw sample, DNA release, its purification, PCR, and 
pyrosequencing. 
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